10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________

FORM 10-Q

_________________________

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 31, 2015

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from________ to________ .

Commission File Number: 1-644

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

DELAWARE	13-1815595
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

300 Park Avenue, New York, New York	10022
(Address of principal executive offices)	(Zip Code)

(212) 310-2000

(Registrant’s telephone number, including area code)

NO CHANGES

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x  No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

Large accelerated filer x	Accelerated filer ¨
Non-accelerated filer ¨	Smaller reporting company ¨

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Shares Outstanding	Date
Common stock, $1.00 par value	904,569,917	March 31, 2015

PART I.FINANCIAL INFORMATION

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Income

 (Dollars in Millions Except Per Share Amounts)

(Unaudited)

	Three Months Ended
	March 31,
	2015		2014
Net sales	$	4,070	$	4,325
Cost of sales	1,678		1,801
Gross profit	2,392		2,524
Selling, general and administrative expenses	1,450		1,544
Other (income) expense, net	82		346
Operating profit	860		634
Interest (income) expense, net	8		7
Income before income taxes	852		627
Provision for income taxes	269		195
Net income including noncontrolling interests	583		432
Less: Net income attributable to noncontrolling interests	41		44
Net income attributable to Colgate-Palmolive Company	$	542	$	388
Earnings per common share, basic	$	0.60	$	0.42
Earnings per common share, diluted	$	0.59	$	0.42
Dividends declared per common share *	$	0.74	$	0.70

* Two dividends were declared in each period.

See Notes to Condensed Consolidated Financial Statements.

2

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Comprehensive Income

 (Dollars in Millions)

(Unaudited)

	Three Months Ended
	March 31,
	2015			2014
Net income including noncontrolling interests	$	583		$	432
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	(351		)	(44		)
Retirement plans and other retiree benefit adjustments	13			13
Gains (losses) on available-for-sale securities	(1		)	(56		)
Gains (losses) on cash flow hedges	—			—
Total Other comprehensive income (loss), net of tax	(339		)	(87		)
Total Comprehensive income including noncontrolling interests	244			345
Less: Net income attributable to noncontrolling interests	41			44
Less: Cumulative translation adjustments attributable to noncontrolling interests	1			(1		)
Total Comprehensive income attributable to noncontrolling interests	42			43
Total Comprehensive income attributable to Colgate-Palmolive Company	$	202		$	302

See Notes to Condensed Consolidated Financial Statements.

3

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Balance Sheets

 (Dollars in Millions)

(Unaudited)

	March 31, 2015			December 31, 2014
Assets
Current Assets
Cash and cash equivalents	$	859		$	1,089
Receivables (net of allowances of $58 and $54, respectively)	1,611			1,552
Inventories	1,350			1,382
Other current assets	880			840
Total current assets	4,700			4,863
Property, plant and equipment:
Cost	8,212			8,385
Less: Accumulated depreciation	(4,244		)	(4,305		)
	3,968			4,080
Goodwill	2,186			2,307
Other intangible assets, net	1,356			1,413
Deferred income taxes	79			76
Other assets	867			720
Total assets	$	13,156		$	13,459
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable	$	18		$	16
Current portion of long-term debt	488			488
Accounts payable	1,167			1,231
Accrued income taxes	417			294
Other accruals	2,233			1,917
Total current liabilities	4,323			3,946
Long-term debt	5,622			5,644
Deferred income taxes	233			261
Other liabilities	2,239			2,223
Total liabilities	12,417			12,074
Shareholders’ Equity
Common stock	1,466			1,466
Additional paid-in capital	1,272			1,236
Retained earnings	18,704			18,832
Accumulated other comprehensive income (loss)	(3,847		)	(3,507		)
Unearned compensation	(13		)	(20		)
Treasury stock, at cost	(17,122		)	(16,862		)
Total Colgate-Palmolive Company shareholders’ equity	460			1,145
Noncontrolling interests	279			240
Total shareholders’ equity	739			1,385
Total liabilities and shareholders’ equity	$	13,156		$	13,459

See Notes to Condensed Consolidated Financial Statements.

4

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Cash Flows

(Dollars in Millions)

(Unaudited)

	Three Months Ended
	March 31,
	2015			2014
Operating Activities
Net income including noncontrolling interests	$	583		$	432
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	114			108
Restructuring and termination benefits, net of cash	57			45
Venezuela remeasurement charges	—			266
Stock-based compensation expense	32			34
Deferred income taxes	(22		)	(21		)
Cash effects of changes in:
Receivables	(150		)	(77		)
Inventories	(23		)	(67		)
Accounts payable and other accruals	111			100
Other non-current assets and liabilities	25			—
Net cash provided by operations	727			820
Investing Activities
Capital expenditures	(122		)	(168		)
Purchases of marketable securities and investments	(252		)	(151		)
Proceeds from sale of marketable securities and investments	110			74
Payment for acquisitions, net of cash acquired	—			(25		)
Other	7			21
Net cash used in investing activities	(257		)	(249		)
Financing Activities
Principal payments on debt	(2,171		)	(1,938		)
Proceeds from issuance of debt	2,105			2,960
Dividends paid	(329		)	(316		)
Purchases of treasury shares	(374		)	(453		)
Proceeds from exercise of stock options and excess tax benefits	128			50
Net cash (used in) provided by financing activities	(641		)	303
Effect of exchange rate changes on Cash and cash equivalents	(59		)	(41		)
Net (decrease) increase in Cash and cash equivalents	(230		)	833
Cash and cash equivalents at beginning of the period	1,089			962
Cash and cash equivalents at end of the period	$	859		$	1,795
Supplemental Cash Flow Information
Income taxes paid	$	164		$	171

See Notes to Condensed Consolidated Financial Statements.

5

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

1. Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission.

2. Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

3. Recent Accounting Pronouncements

On April 7, 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03 “Simplifying the Presentation of Debt Issuance Costs,” which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of related debt liability, consistent with debt discounts. Under current accounting standards, such costs are recorded as an asset. The new guidance is effective for the Company beginning January 1, 2016, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On February 18, 2015, the FASB issued ASU No. 2015-02 “Consolidation (Topic 810): Amendments to the Consolidation Analysis” that amends the current consolidation guidance. The amendments affect both the variable interest entity and voting interest entity consolidation models. The new guidance is effective for the Company beginning January 1, 2016, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On May 28, 2014, the FASB and the International Accounting Standards Board (“IASB”) issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09 “Revenue from Contracts with Customers” by the FASB, provides a single, comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures which are significantly more comprehensive than those in existing revenue standards. This new guidance is currently effective for the Company beginning January 1, 2017, with no early adoption permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.

6

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

4. Acquisitions and Divestitures

Acquisition

On October 3, 2014, the Company acquired an oral care business in Myanmar for $62 in cash plus additional consideration contingent upon achievement of performance targets under a distribution services agreement.

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America (the “Purchaser”) the Mexico City site on which its commercial operations, technology center and soap production facility were located. The sale price is payable in three installments. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The parties subsequently amended that agreement to extend the closing date and are in the process of negotiating an additional amendment. Under the existing agreement, the final installment of the purchase price is due upon the transfer of the property, which is subject to the Company’s satisfaction of certain closing conditions relating to site preparation by May 19, 2015. While these conditions are not expected to be fully satisfied by May 19, 2015, in which case the Purchaser has several options under the agreement (including termination and the return to it of the first two installments of the purchase price), based on the discussions to date, the Company believes that the transfer of the property is still likely to occur in 2015. The Company has reinvested the first two installments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months endedMarch 31, 2015 and 2014, the Company recorded $0 and $1 of pretax costs ($0 and $1 of aftertax costs), respectively, related to the sale.

5. Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

On October 23, 2014, the Company’s Board of Directors approved an expansion of the Global Growth and Efficiency Program (as expanded, the “2012 Restructuring Program”) to take advantage of additional savings opportunities.

Cumulative pretax charges related to the 2012 Restructuring Program, once all phases are approved and implemented, are estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax). Implementation of the 2012 Restructuring Program is expected to be substantially completed by December 31, 2016. These pretax charges are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (20%). Anticipated pretax charges for 2015 are expected to amount to approximately $330 to $385 ($245 to $285 aftertax). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, by the end of 2016, the 2012 Restructuring Program will contribute a net reduction of approximately 2,000-2,500 positions from the Company’s global employee workforce.

7

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

For the three months ended March 31, 2015 and 2014, restructuring and implementation-related charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended March 31,
	2015		2014
Cost of sales	$	4	$	10
Selling, general and administrative expenses	18		17
Other (income) expense, net	78		75
Total 2012 Restructuring Program charges, pretax	$	100	$	102
Total 2012 Restructuring Program charges, aftertax	$	67	$	73

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

					Program-to-date
	Three Months Ended March 31,				Accumulated Charges
	2015		2014
North America	18	%	9	%	11	%
Latin America	—	%	4	%	3	%
Europe/South Pacific	7	%	21	%	25	%
Asia	—	%	—	%	1	%
Africa/Eurasia	3	%	2	%	5	%
Hill’s Pet Nutrition	4	%	8	%	8	%
Corporate	68	%	56	%	47	%

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $846 ($623 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2015
Employee-Related Costs	$	330
Incremental Depreciation	57
Asset Impairments	2
Other	457
Total	$	846

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the extension of shared business services and streamlining of global functions; restructuring how the Company will provide future retirement benefits to substantially all of its U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the closing of the Morristown, New Jersey personal care facility.

8

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2015
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2014	$	85		$	—		$	—	$	107		$	192
Charges	35			6			—		59			100
Cash payments	(15		)	—			—		(26		)	(41		)
Charges against assets	(8		)	(6		)	—		—			(14		)
Foreign exchange	(5		)	—			—		(1		)	(6		)
Balance at March 31, 2015	$	92		$	—		$	—	$	139		$	231

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $8 for the three months ended March 31, 2015, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2015 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $12 and contract termination costs and charges resulting directly from exit activities of $3 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2015 are other exit costs of $44 related to the consolidation of facilities.

9

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

6. Inventories

Inventories by major class are as follows:

	March 31, 2015		December 31, 2014
Raw materials and supplies	$	323	$	349
Work-in-process	56		55
Finished goods	971		978
Total Inventories	$	1,350	$	1,382

7. Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the three months endedMarch 31, 2015 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2014	$	1,466	$	1,236		$	(20	)	$	(16,862	)	$	18,832		$	(3,507	)	$	240
Net income												542						41
Other comprehensive income (loss), net of tax															(340		)	1
Dividends												(670		)				(3		)
Stock-based compensation expense			32
Shares issued for stock options			32						85
Shares issued for restricted stock awards			(29		)				29
Treasury stock acquired									(374		)
Other			1			7
Balance, March 31, 2015	$	1,466	$	1,272		$	(13	)	$	(17,122	)	$	18,704		$	(3,847	)	$	279

Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,805 and $2,453 at March 31, 2015 and December 31, 2014, respectively, and unrecognized retirement plan and other retiree benefits costs of $1,051 and $1,064 at March 31, 2015 and December 31, 2014, respectively.

10

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

8. Earnings Per Share

	Three Months Ended
	March 31, 2015					March 31, 2014
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	542	907.7	$	0.60	$	388	919.5	$	0.42
Stock options and restricted stock units			8.6					9.1
Diluted EPS	$	542	916.3	$	0.59	$	388	928.6	$	0.42

For the three months endedMarch 31, 2015 and 2014, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,566,993 and 3,374,995, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

11

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

9. Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedMarch 31, 2015 and 2014 were as follows:

	2015						2014
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	(340	)	$	(352	)	$	(39	)	$	(43	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	(1		)	(1		)	3			2
Amortization of net actuarial loss, transition and prior service costs (1)	22			14			14			11
Retirement plans and other retiree benefits adjustments	21			13			17			13
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities (2)	(1		)	(1		)	(298		)	(194		)
Reclassification of (gains) losses into net earnings on available-for-sale securities (3)	—			—			211			138
Gains (losses) on available-for-sale securities	(1		)	(1		)	(87		)	(56		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	6			4			2			1
Reclassification of (gains) losses into net earnings on cash flow hedges (4)	(6		)	(4		)	(3		)	(1		)
Gains (losses) on cash flow hedges	—			—			(1		)	—
Total Other comprehensive income (loss)	$	(320	)	$	(340	)	$	(110	)	$	(86	)

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

⁽³⁾Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽⁴⁾These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

12

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

10. Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three months ended March 31, 2015 and 2014 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended March 31,
	2015			2014			2015			2014			2015			2014
Service cost	$	—		$	—		$	5		$	5		$	4		$	3
Interest cost	25			25			8			9			11			10
Expected return on plan assets	(29		)	(27		)	(8		)	(7		)	(1		)	—
Amortization of transition and prior service costs (credits)	—			—			—			1			—			—
Amortization of actuarial loss (gain)	12			8			3			1			7			4
Net periodic benefit cost	$	8		$	6		$	8		$	9		$	21		$	17

For the three months endedMarch 31, 2015 and March 31, 2014, the Company did not make any voluntary contributions to its U.S. postretirement plans.

11. Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $200 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

13

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $90. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process since October 2001. Numerous appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts. The Company intends to challenge these assessments vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $55, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company has been disputing the assessment within the internal revenue authority’s administrative appeals process. In November 2014, the Superior Chamber of Administrative Tax Appeals denied the Company’s most recent appeal. Further appeals are available both at the administrative level and within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

14

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Competition Matters

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues, as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

European Competition Matters

Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases fines, by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court.

▪ In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) pursuant to a Business and Share Sale and Purchase Agreement (the “Sanex Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is entitled to indemnification for this fine under the Sanex Purchase Agreement and is seeking indemnification from Unilever. The Company is appealing both fines in the French courts.

Currently, formal claims of violations or statements of objections are pending against the Company as follows:

▪ In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices in the Belgian market. The defendants have initiated preliminary talks with the authority regarding a possible settlement.

▪ In July 2014, the Greek competition law authority issued a statement of objections alleging the Company and its Greek subsidiary restricted parallel imports into Greece. The Company has responded to this statement of objections.

Since December 31, 2014, the following matter has been resolved:

▪ In March 2015, the French Supreme Court confirmed the French competition law authority’s March 2012 fine of the Company’s Hill’s French subsidiary in the amount of $7.

15

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Australian Competition Matter

In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra concentrated laundry detergents. The Company is defending these proceedings. Since the amount of any potential losses from these proceedings currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings.

Talcum Powder Matters

The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. The Company is challenging these cases vigorously. Nineteen cases filed against the Company have been dismissed and had final judgment entered in favor of the Company. In April 2015, an agreement in principle was reached to settle four individual cases following a trial and jury verdict in one of the cases in California against the Company and others. The amount of the settlement in principle is not material to the Company’s results of operations for the quarter ended March 31, 2015.

There are 13 additional individual cases pending against the Company in state courts in Illinois, Maryland, New Jersey, New York and South Carolina. Some of these cases are expected to go to trial in 2015, although the Company may succeed in dismissing or otherwise resolving them. While the Company and its legal counsel believe these cases are without merit and intend to challenge them vigorously, there can be no assurances of the outcome at trial. Since the amount of any potential losses from these additional cases currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

16

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

12. Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended
	March 31,
	2015			2014
Net sales
Oral, Personal and Home Care
North America	$	789		$	785
Latin America	1,087			1,152
Europe/South Pacific	741			865
Asia	661			672
Africa/Eurasia	254			298
Total Oral, Personal and Home Care	3,532			3,772
Pet Nutrition	538			553
Total Net sales	$	4,070		$	4,325
Operating profit
Oral, Personal and Home Care
North America	$	218		$	216
Latin America	308			290
Europe/South Pacific	184			217
Asia	193			193
Africa/Eurasia	39			59
Total Oral, Personal and Home Care	942			975
Pet Nutrition	147			144
Corporate	(229		)	(485		)
Total Operating profit	$	860		$	634

17

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months endedMarch 31, 2015, Corporate Operating profit (loss) includes charges of $100 related to the 2012 Restructuring Program. For the three months endedMarch 31, 2014, Corporate Operating profit (loss) included charges of $102 related to the 2012 Restructuring Program, a charge of $266 related to the 2014 Venezuela Remeasurements and costs of $1 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures.

13. Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.  

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

18

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2015 and December 31, 2014:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		3/31/15		12/31/14			3/31/15		12/31/14
Interest rate swap contracts	Other current assets	$	1	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	16		12		Other liabilities	—		2
Foreign currency contracts	Other current assets	36		21		Other accruals	18		4
Foreign currency contracts	Other assets	121		60		Other liabilities	—		—
Commodity contracts	Other current assets	—		—		Other accruals	1		1
Total designated		$	174	$	94		$	19	$	7
Derivatives not designated
Foreign currency contracts	Other assets	$	13	$	8	Other liabilities	$	—	$	—
Total not designated		$	13	$	8		$	—	$	—
Total derivative instruments		$	187	$	102		$	19	$	7
Other financial instruments
Marketable securities	Other current assets	$	250	$	200
Available-for-sale securities	Other assets	398		322
Note receivable	Other current assets	42		42
Total other financial instruments		$	690	$	564

The carrying amount of cash, cash equivalents, accounts receivable, a note receivable and short-term debt approximated fair value as of March 31, 2015 and December 31, 2014. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2015 and December 31, 2014, was $6,463 and $6,346, respectively, and the related carrying value was $6,110 and $6,132, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

19

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Fair Value Hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015									2014
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at March 31,	$	1,213		$	1,438		$	2,651		$	681		$	1,688		$	2,369
Three months ended March 31:
Gain (loss) on derivative	2			6			8			2			(10		)	(8		)
Gain (loss) on hedged items	(2		)	(6		)	(8		)	(2		)	10			8

Cash Flow Hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015							2014
	Foreign Currency Contracts		Commodity Contracts			Total		Foreign Currency Contracts		Commodity Contracts		Total
Notional Value at March 31,	$	595	$	12		$	607	$	401	$	15	$	416
Three months ended March 31:
Gain (loss) recognized in OCI	7		(1		)	6		—		2		2
Gain (loss) reclassified into Cost of sales	7		(1		)	6		2		1		3

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

20

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Net Investment Hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015									2014
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts		Foreign Currency Debt			Total
Notional Value at March 31,	$	768		$	273		$	1,041		$	680	$	256		$	936
Three months ended March 31:
Gain (loss) on instruments	62			27			89			—		1			1
Gain (loss) on hedged items	(62		)	(27		)	(89		)	1		(1		)	—

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. 

Activity related to this contract during the three months ended March 31, 2015 and 2014 was as follows:

	2015			2014
	Cross-currency Swap			Cross-currency Swap
Notional Value at March 31,	$	102		$	96
Three months ended March 31:
Gain (loss) on instrument	5			(1		)
Gain (loss) on hedged item	(5		)	1

21

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities and a fixed interest rate note receivable. Marketable securities consist of bank deposits of $217 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $33. The long-term portion of these bonds in the amount of $398 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and bolivar denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of March 31, 2015, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds was $72 and $359, respectively. These bonds are considered available-for-sale securities and, as noted above, the long-term portion in the amount of $398 is included in Other assets.

The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months endedMarch 31, 2015 and 2014:

	2015			2014
Beginning balance as of January 1,	$	399		$	685
Unrealized gain (loss) on investment	(1		)	(298		)
Purchases and sales during the period	33			54
Ending balance as of March 31,	$	431		$	441

Unrealized loss on investment for the three months endedMarch 31, 2014 consisted primarily of a charge of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

For further information regarding Venezuela, refer to Note 14, Venezuela.

22

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

14. Venezuela

Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.

In February 2015, the Venezuelan government implemented changes in Venezuela’s foreign exchange regime. While the official exchange rate, as determined by the National Center for Foreign Commerce (“CENCOEX”), remains at 6.30 bolivares per dollar and the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market, now known as SICAD, is unchanged, the SICAD II market was eliminated and a new, alternative currency market, the Foreign Exchange Marginal System (“SIMADI”), was created and became operational with a floating exchange rate determined by market participants.

The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is currently the SICAD rate. During the quarter ended March 31, 2015, the SICAD rate did not revalue, remaining at 12.00 bolivares per dollar as of March 31, 2015.

During the quarter ended March 31, 2014, the Company incurred pretax losses of $266 ($174 aftertax losses, or $0.19 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD rate. Included in the remeasurement losses were charges related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remained at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD currency market but remained at the official exchange rate, resulting in an impairment in the fair value of the bonds.

CP Venezuela funds its requirements for imported goods through a combination of U.S. dollars obtained from CENCOEX and intercompany borrowings. Because most of the products in CP Venezuela’s portfolio have been designated as “essential” by the Venezuelan government, CP Venezuela’s access to U.S. dollars at the official rate of 6.30 bolivares per dollar has generally been sufficient to settle most of its U.S. dollar obligations for imported materials and the gains related to such transactions are recorded when the funds are authorized by CENCOEX and the liabilities are paid.

Although the SIMADI market was accessible to CP Venezuela, it did not participate in the market through March 31, 2015. Since its inception, the volume of transactions in the SIMADI market has been very limited and the exchange rate at March 31, 2015 was 192.95 bolivares per dollar.

For the three months endedMarch 31, 2015, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At March 31, 2015, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD rate, was $589. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated net non-monetary assets were $302 at March 31, 2015 and included $234 of fixed assets that could be subject to impairment if CP Venezuela is not able to implement further price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars from CENCOEX or the SICAD market to fund imports.

Additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing, payments, profits or imports or other governmental actions or continued or increased labor unrest would further negatively affect the Company’s business in Venezuela and the Company’s ability to effectively make key operational decisions in regard to its Venezuelan operations, both of which could result in an impairment of the Company’s investment in CP Venezuela. At March 31, 2015, the Company’s total investment in CP Venezuela was $987, which included intercompany payables of CP Venezuela.

23

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Executive Overview and Outlook

Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to develop and increase market leadership positions in key product categories. These product categories are prioritized based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is operated through five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through authorized pet supply retailers and veterinarians.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), gross profit margin, operating profit, net income and earnings per share, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators and the Company’s Code of Conduct and corporate governance practices help to maintain business health and strong internal controls.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products regionally, which are then rolled out on a global basis. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental and veterinary professionals and retail customers. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.

The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as the Company’s funding-the-growth initiatives, the Company seeks to become even more effective and efficient throughout its businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses and distribution and logistics, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.

24

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

With approximately 80% of its Net sales generated outside the United States, the Company is exposed to changes in economic conditions and foreign currency exchange rates, as well as political uncertainty in some countries, all of which could impact future operating results. For example, as discussed in detail below, the operating environment in Venezuela is challenging, with economic uncertainty fueled by currency devaluations in 2010 and 2013 and the effective devaluations in 2014, high inflation and the decline in the price of oil, and governmental restrictions in the form of import authorization controls, currency exchange and payment controls, price and profit controls and the possibility of expropriation of property or other resources. In addition, at times, the Company’s production in Venezuela has also been negatively impacted by labor issues within the country. Price controls, which became effective in April 2012, affect most products in the portfolio of the Company’s Venezuelan subsidiary (“CP Venezuela”) and restrict the Company’s ability to implement price increases without government approval, which has limited the Company’s ability to offset the effects of continuing high inflation and the impact of currency devaluations. In addition, during the first quarter of 2014, the Venezuelan government issued a new Law on Fair Pricing, establishing a maximum profit margin of 30% for products and services. The Company’s business in Venezuela and the Company’s ability to repatriate its earnings continue to be negatively affected by these difficult conditions.

In February 2015, the Venezuelan government implemented changes in Venezuela’s foreign exchange regime. While the official exchange rate, as determined by the National Center for Foreign Commerce (“CENCOEX”), remains at 6.30 bolivares per dollar and the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market, now known as SICAD, is unchanged, the SICAD II market was eliminated and a new, alternative currency market, the Foreign Exchange Marginal System (“SIMADI”), was created and became operational with a floating exchange rate determined by market participants.

The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is currently the SICAD rate. During the quarter ended March 31, 2015, the SICAD rate did not revalue, remaining at 12.00 bolivares per dollar as of March 31, 2015.

There continue to be ongoing impacts primarily related to the translation of the local financial statements and, to a lesser degree, the import of materials at the SICAD exchange rate as most imports still qualify for the official rate. Because the SICAD market is auction-based and auctions are held periodically during the year, the exchange rate available through SICAD may vary throughout the year which would cause additional remeasurements of CP Venezuela’s local currency-denominated net monetary assets and further impact CP Venezuela’s ongoing results.

Although the SIMADI market was accessible to CP Venezuela, it did not participate in the market through March 31, 2015. Since its inception, the volume of transactions in the SIMADI market has been very limited and the exchange rate at March 31, 2015 was 192.95 bolivares per dollar.

During the quarter ended March 31, 2014, the Company incurred pretax losses of $266 ($174 aftertax losses, or $0.19 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD rate. Included in the remeasurement losses were charges related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remained at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD currency market but remained at the official exchange rate, resulting in an impairment in the fair value of the bonds. The net remeasurement losses incurred in the quarter ended March 31, 2014 are referred to as the “2014 Venezuela Remeasurements.”

During the third quarter of 2014, the Venezuelan government approved price increases for the majority of CP Venezuela’s product portfolio, which were implemented in the fourth quarter of 2014.

25

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

CP Venezuela funds its requirements for imported goods through a combination of U.S. dollars obtained from CENCOEX and intercompany borrowings. Because most of the products in CP Venezuela’s portfolio have been designated as “essential” by the Venezuelan government, CP Venezuela’s access to U.S. dollars at the official rate of 6.30 bolivares per dollar has generally been sufficient to settle most of its U.S. dollar obligations for imported materials and the gains related to such transactions are recorded when the funds are authorized by CENCOEX and the liabilities are paid. However, CP Venezuela’s supply of U.S. dollars to fund imports has been limited and sporadic. CP Venezuela was invited to participate in the SICAD currency market during the second and fourth quarters of 2014 and received less than $1 in each of those quarters at rates of 10.50 bolivares per dollar and 12.00 bolivares per dollar, respectively. No SICAD auctions were held during the first quarter of 2015. CP Venezuela’s difficulty in accessing U.S. dollars to support its operations has had and is expected to continue to have an adverse effect on the business. Additionally, the decline in the price of oil may result in reduced availability of U.S. dollars in Venezuela to fund CP Venezuela’s imports. If CP Venezuela is unable to obtain sufficient U.S. dollars from CENCOEX or the SICAD market to fund its requirements for imported goods and instead needs to access the SIMADI market, it could significantly impact the Company’s operations in Venezuela.

For the three months endedMarch 31, 2015, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales and approximately 3% of the Company’s consolidated Operating profit excluding charges related to the 2012 Restructuring Program. At March 31, 2015, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD rate, was $589. This amount includes the devaluation-protected bonds issued by the Venezuelan government. If the Company had to use the SIMADI rate to remeasure CP Venezuela’s local currency-denominated net monetary asset position at March 31, 2015, which could occur if CP Venezuela were unable to continue to obtain sufficient U.S. dollars from CENCOEX or SICAD to fund its requirements for imported goods, the Company would have incurred a remeasurement loss related to CP Venezuela’s local currency-denominated net monetary assets of approximately $500 ($321 aftertax loss, or $0.35 per diluted common share). CP Venezuela’s local currency-denominated net non-monetary assets were $302 at March 31, 2015 and included $234 of fixed assets that could be subject to impairment if CP Venezuela is not able to implement further price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars from CENCOEX or the SICAD market to fund imports. Additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing, payments, profits or imports or other governmental actions or continued or increased labor unrest would further negatively affect the Company’s business in Venezuela and the Company’s ability to effectively make key operational decisions in regard to its Venezuelan operations, both of which could result in an impairment of the Company’s investment in CP Venezuela. At March 31, 2015, the Company’s total investment in CP Venezuela was $987, which included intercompany payables of CP Venezuela. The Company continues to actively manage its investment in and limit its exposure to Venezuela.

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program for sustained growth. The program’s initiatives are expected to help the Company ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

On October 23, 2014, the Company’s Board of Directors (the “Board”) approved an expansion of the Global Growth and Efficiency Program (as expanded, the “2012 Restructuring Program”). The initiatives under the 2012 Restructuring Program continue to be focused on the following areas:

▪ Expanding Commercial Hubs

▪ Extending Shared Business Services and Streamlining Global Functions

▪ Optimizing Global Supply Chain and Facilities

The Board authorized the expansion of the 2012 Restructuring Program to take advantage of additional savings opportunities identified in all three areas.

26

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Cumulative pretax charges related to the 2012 Restructuring Program, once all phases are approved and implemented, are estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax). Implementation of the 2012 Restructuring Program is expected to be substantially completed by December 31, 2016. Savings, substantially all of which are expected to increase future cash flows, are projected to be approximately $405 to $475 pretax ($340 to $390 aftertax) annually by the fourth year of the program. For more information regarding the 2012 Restructuring Program, see “Restructuring and Related Implementation Charges” below.

In the first quarter of 2015, the Company incurred aftertax costs of $67 associated with the 2012 Restructuring Program.

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America (the “Purchaser”) the Mexico City site on which its commercial operations, technology center and soap production facility were located. The parties subsequently amended that agreement to extend the closing date and are in the process of negotiating an additional amendment. Under the existing agreement, the final installment of the purchase price is due upon the transfer of the property, which is subject to the Company’s satisfaction of certain closing conditions relating to site preparation by May 19, 2015. While these conditions are not expected to be fully satisfied by May 19, 2015, in which case the Purchaser has several options under the agreement (including termination and the return to it of the first two installments of the purchase price), based on the discussions to date, the Company believes that the transfer of the property is still likely to occur in 2015. The Company has reinvested the first two installments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready.

Looking forward, the Company expects global macroeconomic and market conditions to remain highly challenging. While the global marketplace in which the Company operates has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from local competitors and other large multinational companies, some of which have greater resources than the Company does. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. Additionally, the Company continues to experience volatile foreign currency fluctuations and high raw and packaging material costs, driven by foreign exchange transaction costs. While the Company has taken, and will continue to take, measures to mitigate the effect of these conditions, should they persist, they could adversely affect the Company’s future results.

The Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s strategic initiatives: engaging to build our brands; innovation for growth; effectiveness and efficiency; and leading to win. This focus, together with the strength of the Company’s global brand names, its broad international presence in both mature and emerging markets and initiatives, such as the 2012 Restructuring Program, should position the Company well to increase shareholder value over the long term.

27

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Results of Operations

Three Months

Net Sales

Worldwide Net sales were $4,070 in the first quarter of 2015, down 6.0% from the first quarter of 2014, as volume growth of 1.5% and net selling price increases of 2.5% were more than offset by negative foreign exchange of 10.0%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure as discussed below, increased 4.0% in the first quarter of 2015.

Net sales in the Oral, Personal and Home Care product segment were $3,532 in the first quarter of 2015, down 6.5% from the first quarter of 2014, as volume growth of 1.5% and net selling price increases of 2.5% were more than offset by negative foreign exchange of 10.5%. Organic sales in the Oral, Personal and Home Care product segment increased 4.0% in the first quarter of 2015.

The increase in organic sales in the first quarter of 2015 versus the first quarter of 2014 was driven by an increase in Oral Care organic sales with the toothpaste and the manual toothbrush categories contributing to growth. Personal Care and Home Care also contributed to organic sales growth. The increase in Personal Care organic sales was due to strong growth in the bar soap and the shower gel categories. Home Care organic sales growth was driven by gains in the fabric softener category.

The Company’s share of the global toothpaste market was 45.2% on a year-to-date basis, up 0.7% from the year ago period, and its share of the global manual toothbrush market was 33.8% on a year-to-date basis, up 0.3% from the year ago period. Year-to-date market shares in toothpaste were up in North America, Latin America, Europe/South Pacific and Africa/Eurasia and down in Asia versus the comparable 2014 period. In the manual toothbrush category, year-to-date market shares were up in North America and Europe/South Pacific and down in Latin America, Asia and Africa/Eurasia versus the comparable 2014 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales for Hill’s Pet Nutrition decreased 2.5% in the first quarter of 2015 to $538, as volume growth of 2.0% and net selling price increases of 3.5% were more than offset by negative foreign exchange of 8.0%. Organic sales in Hill’s Pet Nutrition increased 5.5% in the first quarter of 2015. 

The increase in organic sales in the first quarter of 2015 versus the first quarter of 2014 was driven by continued organic sales growth in the Prescription Diet category. The Advanced Nutrition and Naturals categories also contributed to organic sales growth.

28

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Gross Profit/Margin

Worldwide Gross profit decreased 5% to $2,392 in the first quarter of 2015 from $2,524 in the first quarter of 2014. Gross profit in both periods included charges related to the 2012 Restructuring Program. Gross profit in the first quarter of 2014 also included costs related to the sale of land in Mexico. Excluding these items in both periods as applicable, Gross profit decreased to $2,396 in the first quarter of 2015 from $2,535 in the first quarter of 2014, primarily due to lower sales ($150), as the growth in organic sales was more than offset by the impact of negative foreign exchange, partially offset by higher Gross profit margin ($11).

Worldwide Gross profit margin increased to 58.8% in the first quarter of 2015 from 58.4% in the first quarter of 2014.  Excluding the items described above in both periods as applicable, Gross profit margin increased by 30 bps to 58.9% in the first quarter of 2015 from 58.6% in the first quarter of 2014, as higher pricing (100 bps) and cost savings from the Company’s funding-the-growth initiatives (160 bps) and the 2012 Restructuring Program (10 bps) more than offset higher raw and packaging material costs (230 bps), driven by significant foreign exchange transaction costs.

	Three Months Ended March 31,
	2015		2014
Gross profit, GAAP	$	2,392	$	2,524
2012 Restructuring Program	4		10
Costs related to the sale of land in Mexico	—		1
Gross profit, non-GAAP	$	2,396	$	2,535

	Three Months Ended March 31,
	2015		2014		Basis Point Change
Gross profit margin, GAAP	58.8	%	58.4	%	40
2012 Restructuring Program	0.1		0.2
Costs related to the sale of land in Mexico	—		—
Gross profit margin, non-GAAP	58.9	%	58.6	%	30

29

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased 6% to $1,450 in the first quarter of 2015 from $1,544 in the first quarter of 2014. Selling, general and administrative expenses in both periods included charges related to the 2012 Restructuring Program. Excluding these charges, Selling, general and administrative expenses decreased to $1,432 in the first quarter of 2015 from $1,527 in the first quarter of 2014, reflecting decreased advertising investment ($48) and lower overhead expenses ($47).

Selling, general and administrative expenses as a percentage of Net sales decreased to 35.6% in the first quarter of 2015 from 35.7% in the first quarter of 2014. Excluding charges related to the 2012 Restructuring Program, Selling, general and administrative expenses as a percentage of Net sales were 35.2% in the first quarter of 2015, a decrease of 10 bps as compared to the first quarter of 2014. This decrease was a result of decreased advertising investment (50 bps), partially offset by higher overhead expenses (40 bps), both as a percentage of Net sales. In the first quarter of 2015, advertising investment decreased 10.0% to $430, as compared with $478 in the first quarter of 2014, and decreased as a percentage of Net sales to 10.6% in the first quarter of 2015 from 11.1% in the first quarter of 2014.

	Three Months Ended March 31,
	2015			2014
Selling, general and administrative expenses, GAAP	$	1,450		$	1,544
2012 Restructuring Program	(18		)	(17		)
Selling, general and administrative expenses, non-GAAP	$	1,432		$	1,527

	Three Months Ended March 31,
	2015		2014		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.6	%	35.7	%	(10	)
2012 Restructuring Program	(0.4	)	(0.4	)
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP	35.2	%	35.3	%	(10	)

30

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Other (Income) Expense, Net

Other (income) expense, net was $82 in the first quarter of 2015, as compared to $346 in the first quarter of 2014. Other (income) expense, net in both periods included charges related to the 2012 Restructuring Program. Other (income) expense, net in the first quarter of 2014 also included a charge related to the 2014 Venezuela Remeasurements. Excluding these charges in both periods as applicable, Other (income) expense, net was $4 in the first quarter of 2015, as compared to $5 in the first quarter of 2014.

	Three Months Ended March 31,
	2015			2014
Other (income) expense, net, GAAP	$	82		$	346
2012 Restructuring Program	(78		)	(75		)
Venezuela remeasurement charges	—			(266		)
Other (income) expense, net, non-GAAP	$	4		$	5

Operating Profit

Operating profit increased 36% to $860 in the first quarter of 2015 from $634 in the first quarter of 2014. Operating profit in both periods included charges related to the 2012 Restructuring Program. Operating profit in the first quarter of 2014 also included a charge related to the 2014 Venezuela Remeasurements and costs related to the sale of land in Mexico. Excluding these items in both periods as applicable, Operating profit decreased 4% to $960 in the first quarter of 2015 from $1,003 in the first quarter of 2014, primarily due to lower Gross profit, which was partially offset by the decrease in Selling, general and administrative expenses.

Operating profit margin was 21.1% in the first quarter of 2015, an increase of 640 bps compared to 14.7% in the first quarter of 2014. Excluding the items described above in both periods as applicable, Operating profit margin increased 40 bps to 23.6% in the first quarter of 2015 as compared to 23.2% in the first quarter of 2014. This increase in Operating profit margin was due to an increase in Gross profit margin (30 bps) and a decrease in Selling, general and administrative expenses as a percentage of Net sales (10 bps).

	Three Months Ended March 31,
	2015		2014		% Change
Operating profit, GAAP	$	860	$	634	36	%
2012 Restructuring Program	100		102
Venezuela remeasurement charges	—		266
Costs related to the sale of land in Mexico	—		1
Operating profit, non-GAAP	$	960	$	1,003	(4	)%

	Three Months Ended March 31,
	2015		2014		Basis Point Change
Operating profit margin, GAAP	21.1	%	14.7	%	640
2012 Restructuring Program	2.5		2.3
Venezuela remeasurement charges	—		6.2
Operating profit margin, non-GAAP	23.6	%	23.2	%	40

31

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Interest (Income) Expense, Net

Interest (income) expense, net was $8 in the first quarter of 2015 as compared to $7 in the first quarter of 2014, primarily due to lower interest income on investments held outside the United States.

Income taxes

The effective tax rate was 31.6% for the first quarter of 2015 as compared to 31.1% for the first quarter of 2014. The quarterly provision for income taxes is determined based on the Company’s estimated full year effective tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 31.5%, compared to 31.7% in the first quarter of 2014. As reflected in the table below, the non-GAAP effective income tax rate was 31.5% for the three-month period ended March 31, 2015 as compared to 31.7% in the comparable period of 2014.

	Three Months Ended
	March 31,
	2015		2014
Effective tax rate, GAAP	31.6	%	31.1	%
2012 Restructuring Program	(0.1	)	(0.4	)
Venezuela remeasurement charges	—		1.0
Costs related to the sale of land in Mexico	—		—
Effective tax rate, non-GAAP	31.5	%	31.7	%

Net Income attributable to Colgate-Palmolive Company and Earnings per share

Net income attributable to Colgate-Palmolive Company for the first quarter of 2015 increased to $542 from $388 in the first quarter of 2014, and Earnings per common share on a diluted basis increased to $0.59 per share in the first quarter of 2015 from $0.42 per share in the first quarter of 2014. Net income attributable to Colgate-Palmolive Company in both periods included charges related to the 2012 Restructuring Program. Net income attributable to Colgate-Palmolive Company in the first quarter of 2014 also included a charge related to the 2014 Venezuela Remeasurements and costs related to the sale of land in Mexico.

Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the first quarter of 2015 decreased 4% to $609 and Earnings per common share on a diluted basis decreased 3% to $0.66.

	Three Months Ended March 31,
	2015		2014		% Change
Net income attributable to Colgate-Palmolive Company, GAAP	$	542	$	388	40	%
2012 Restructuring Program	67		73
Venezuela remeasurement charges	—		174
Costs related to the sale of land in Mexico	—		1
Net income attributable to Colgate-Palmolive Company, non-GAAP	$	609	$	636	(4	)%

	Three Months Ended March 31,
	2015		2014		% Change
Earnings per common share, diluted, GAAP	$	0.59	$	0.42	40	%
2012 Restructuring Program	0.07		0.07
Venezuela remeasurement charges	—		0.19
Earnings per common share, diluted, non-GAAP	$	0.66	$	0.68	(3	)%

32

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America

	Three Months Ended March 31,
	2015			2014			Change
Net sales	$	789		$	785		0.5	%
Operating profit	$	218		$	216		1	%
% of Net sales	27.6		%	27.5		%	10	bps

Net sales in North America increased 0.5% in the first quarter of 2015 to $789, driven by net selling price increases of 1.5%, as volume was flat and foreign exchange was negative 1%. Organic sales in North America increased 1.5% in the first quarter of 2015.

The increase in organic sales in North America in the first quarter of 2015 versus the first quarter of 2014 was driven by Oral Care with strong organic sales growth in the toothpaste category.

Operating profit in North America increased 1% in the first quarter of 2015 to $218, or 10 bps to 27.6% of Net sales. This increase in Operating profit as a percentage of Net sales was due to an increase in Gross profit (10 bps) and a decrease in Selling, general and administrative expenses (70 bps), partially offset by an increase in Other (income) expense, net (70 bps), all as a percentage of Net sales. This increase in Gross profit was primarily driven by cost savings from the Company’s funding-the-growth initiatives (120 bps) and higher pricing, which more than offset higher costs (180 bps), primarily due to higher raw and packaging material costs. This decrease in Selling, general and administrative expenses was due to decreased advertising investment (70 bps) due to the timing of new product launches. This increase in Other (income) expense, net was due to higher intercompany expense from purchases of inventory from the Latin America reportable operating segment.

33

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Latin America

	Three Months Ended March 31,
	2015			2014			Change
Net sales	$	1,087		$	1,152		(5.5	)	%
Operating profit	$	308		$	290		6		%
% of Net sales	28.3		%	25.2		%	310		bps

Net sales in Latin America decreased 5.5% to $1,087 in the first quarter of 2015. Volume growth of 1.5% and net selling price increases of 8.0% were more than offset by negative foreign exchange of 15.0%. Acquisitions contributed 0.5% to volume. Organic sales in Latin America increased 9.0% in the first quarter of 2015. Volume gains were led by Mexico, Ecuador and Central America and were partially offset by volume declines in Brazil and Venezuela.

The increase in organic sales in Latin America in the first quarter of 2015 versus the first quarter of 2014 was due to an increase in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care organic sales was driven by strong organic sales in the toothpaste category. Personal Care organic sales growth was driven by gains in the bar soap and the underarm protection categories. Home Care organic sales growth was due to strong organic sales in the fabric softener category.

Operating profit in Latin America increased 6% in the first quarter of 2015 to $308, or 310 bps to 28.3% of Net sales. This increase in Operating profit as a percentage of Net sales was due to an increase in Gross profit (150 bps), a decrease in Selling, general and administrative expenses (70 bps) and a decrease in Other (income) expense, net (90 bps), all as a percentage of Net sales. This increase in Gross profit was primarily driven by cost savings from the Company’s funding-the-growth initiatives (130 bps) and the 2012 Restructuring Program (20 bps) and higher pricing, which more than offset higher costs (400 bps), primarily due to higher raw and packaging material costs, driven by foreign exchange transaction costs. This decrease in Selling, general and administrative expenses was due to lower overhead expenses (20 bps) and decreased advertising investment (50 bps), reflecting a shift from advertising investment to in-store promotional activities. This decrease in Other (income) expense, net was primarily due to higher intercompany income from sales of inventory to the North America reportable operating segment.

34

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Europe/South Pacific

	Three Months Ended March 31,
	2015			2014			Change
Net sales	$	741		$	865		(14.5	)	%
Operating profit	$	184		$	217		(15	)	%
% of Net sales	24.8		%	25.1		%	(30	)	bps

Net sales in Europe/South Pacific decreased 14.5% in the first quarter of 2015 to $741. Volume growth of 5.0% was more than offset by net selling price decreases of 4.5% due to increased promotional activities and negative foreign exchange of 15.0%. Divestments decreased volume by 0.5%. Organic sales in Europe/South Pacific increased 1.0% in the first quarter of 2015. Volume gains were led by the United Kingdom, Australia and Germany.

The increase in organic sales in Europe/South Pacific in the first quarter of 2015 versus the first quarter of 2014 was driven by Personal Care with strong organic sales growth in the shower gel and the underarm protection categories.

Operating profit in Europe/South Pacific decreased 15% in the first quarter of 2015 to $184, or 30 bps to 24.8% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses as a percentage of Net sales (20 bps). Gross profit as a percentage of Net sales was even with the first quarter of 2014, as cost savings from the Company’s funding-the-growth initiatives (260 bps) and the 2012 Restructuring Program (50 bps) fully offset higher raw and packaging material costs (180 bps), driven by foreign exchange transaction costs, and the impact of lower pricing due to increased promotional activities. This increase in Selling, general and administrative expenses was due to higher overhead expenses (10 bps) and increased advertising investment (10 bps).

Asia

	Three Months Ended March 31,
	2015			2014			Change
Net sales	$	661		$	672		(1.5	)	%
Operating profit	$	193		$	193		—		%
% of Net sales	29.2		%	28.7		%	50		bps

Net sales in Asia decreased 1.5% in the first quarter of 2015 to $661. Volume growth of 1.0% was more than offset by net selling price decreases of 1.0% due to increased promotional activities and negative foreign exchange of 1.5%. Acquisitions contributed 0.5% to volume. Organic sales in Asia decreased 0.5% in the first quarter of 2015. Volume gains in India, the Philippines and Thailand were partially offset by volume declines in the Greater China region.

The decrease in organic sales in the first quarter of 2015 versus the first quarter of 2014 was due to a decline in organic sales in the Oral Care category, which was partially offset by higher organic sales in the Personal Care category. The decrease in Oral Care organic sales was due to a decline in the toothpaste category, partially offset by an increase in the manual toothbrush category. The increase in Personal Care organic sales was driven by gains in the shampoo category.

Operating profit in Asia was $193 in the first quarter of 2015, even with the first quarter of 2014, while as a percentage of Net sales, it increased 50 bps to 29.2%. This increase in Operating profit as a percentage of Net sales was due to a decrease in Selling, general and administrative expenses (100 bps), which was partially offset by a decrease in Gross profit (50 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (130 bps), which included foreign exchange transaction costs, and lower pricing, partially offset by cost savings from the Company’s funding-the-growth initiatives (140 bps). This decrease in Selling, general and administrative expenses was due to lower overhead expenses (20 bps) and decreased advertising investment (80 bps), the latter due to the timing of new product launches and a shift from advertising investment to in-store promotional activities.

35

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Africa/Eurasia

	Three Months Ended March 31,
	2015			2014			Change
Net sales	$	254		$	298		(15.0	)	%
Operating profit	$	39		$	59		(34	)	%
% of Net sales	15.4		%	19.8		%	(440	)	bps

Net sales in Africa/Eurasia decreased 15.0% in the first quarter of 2015 to $254. Volume growth of 0.5% and net selling price increases of 7.5% were more than offset by negative foreign exchange of 23.0%. Organic sales in Africa/Eurasia grew 8.0% in the first quarter of 2015. Volume gains were led by the Sub-Saharan Africa region and South Africa and were partially offset by volume declines in the Central Asia/Caucasus region.

The increase in organic sales in the first quarter of 2015 versus the first quarter of 2014 was driven by Oral Care with strong organic sales growth in the toothpaste and the manual toothbrush categories. Personal Care and Home Care also contributed to organic sales growth with gains in the bar soap and the fabric softener categories, respectively.

Operating profit in Africa/Eurasia decreased 34% in the first quarter of 2015 to $39, or 440 bps to 15.4% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (290 bps) and an increase in Selling, general and administrative expenses (100 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (680 bps), driven by higher foreign exchange transaction costs, partially offset by cost savings from the Company’s funding-the-growth initiatives (140 bps) and higher pricing. This increase in Selling, general and administrative expenses was due to higher overhead expenses (230 bps), partially offset by decreased advertising investment (130 bps).

Hill’s Pet Nutrition

	Three Months Ended March 31,
	2015			2014			Change
Net sales	$	538		$	553		(2.5	)	%
Operating profit	$	147		$	144		2		%
% of Net sales	27.3		%	26.0		%	130		bps

Net sales for Hill’s Pet Nutrition decreased 2.5% in the first quarter of 2015 to $538. Volume growth of 2.0% and net selling price increases of 3.5% were more than offset by negative foreign exchange of 8.0%. Organic sales in Hill’s Pet Nutrition increased 5.5% in the first quarter of 2015. Volume gains were led by the United States and Australia and were partially offset by volume declines in Japan. The volume declines in Japan were due to the timing of customer shipments in the first quarter of 2014.

The increase in organic sales in the first quarter of 2015 versus the first quarter of 2014 was driven by continued organic sales growth in the Prescription Diet category. The Advanced Nutrition and Naturals categories also contributed to organic sales growth.

Operating profit in Hill’s Pet Nutrition increased 2% in the first quarter of 2015 to $147, or 130 bps to 27.3% of Net sales. This increase in Operating profit as a percentage of Net sales was due to an increase in Gross profit (100 bps) and a decrease in Selling, general and administrative expenses (110 bps), partially offset by an increase in Other (income) expense, net (80 bps), all as a percentage of Net sales. This increase in Gross profit was primarily driven by cost savings from the Company’s funding-the-growth initiatives (170 bps) and higher pricing, which more than offset higher raw and packaging material costs (140 bps), which included foreign exchange transaction costs. This decrease in Selling, general and administrative expenses was primarily due to lower overhead expenses (50 bps) and decreased advertising investment (60 bps). This increase in Other (income) expense, net was in part due to the expiration of a foreign sales tax exemption.

36

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Corporate

	Three Months Ended March 31,
	2015			2014			Change
Operating profit (loss)	$	(229	)	$	(485	)	(53	)	%

Operating profit (loss) related to Corporate was ($229) in the first quarter of 2015 as compared to ($485) in the first quarter of 2014. In the first quarter of 2015, Corporate Operating profit (loss) included charges of $100 related to the 2012 Restructuring Program. In the first quarter of 2014, Corporate Operating profit (loss) included charges of $102 related to the 2012 Restructuring Program, a charge of $266 related to the 2014 Venezuela Remeasurements and costs of $1 related to the sale of land in Mexico.

Restructuring and Related Implementation Charges

2012 Restructuring Program

In the fourth quarter of 2012, the Company commenced the 2012 Restructuring Program. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

The 2012 Restructuring Program is expected to produce significant benefits in the Company’s long-term business performance. The major objectives of the program include:

▪ Becoming even stronger on the ground through the continued evolution and expansion of proven global and regional commercial capabilities, which have already been successfully implemented in a number of the Company’s operations around the world.

▪ Simplifying and standardizing how work gets done by increasing technology-enabled collaboration and taking advantage of global data and analytic capabilities, leading to smarter and faster decisions.

▪ Reducing structural costs to continue to increase the Company’s gross and operating profit.

▪ Building on Colgate’s current position of strength to enhance its leading market share positions worldwide and ensure sustained sales and earnings growth.

On October 23, 2014, the Company’s Board of Directors approved an expansion of the 2012 Restructuring Program. The initiatives under the 2012 Restructuring Program continue to be focused on the following areas:

▪ Expanding Commercial Hubs - Building on the success of this structure already implemented in several divisions, continuing to cluster single-country subsidiaries into more efficient regional hubs, in order to drive smarter and faster decision making, strengthen capabilities available on the ground and improve cost structure.

▪ Extending Shared Business Services and Streamlining Global Functions - Implementing the Company’s shared service organizational model, already successful in Europe, in all regions of the world. Initially focused on finance and accounting, these shared services will be expanded to additional functional areas to streamline global functions.

▪ Optimizing Global Supply Chain and Facilities - Continuing to optimize manufacturing efficiencies, global warehouse networks and office locations for greater efficiency, lower cost and speed to bring innovation to market.

The Board authorized the expansion of the 2012 Restructuring Program to take advantage of additional savings opportunities identified in all three areas.

37

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Cumulative pretax charges related to the 2012 Restructuring Program, once all phases are approved and implemented, are estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax). Implementation of the 2012 Restructuring Program is expected to be substantially completed by December 31, 2016. These pretax charges are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (20%). Anticipated pretax charges for 2015 are expected to amount to approximately $330 to $385 ($245 to $285 aftertax). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, by the end of 2016, the 2012 Restructuring Program will contribute a net reduction of approximately 2,000-2,500 positions from the Company’s global employee workforce.

Savings from the 2012 Restructuring Program, substantially all of which are expected to increase future cash flows, are projected to be in the range of $405 to $475 pretax ($340 to $390 aftertax) annually by the fourth year of the program. Savings in 2015 are expected to amount to approximately $80 to $100 pretax ($60 to $75 aftertax).

For the three months ended March 31, 2015 and 2014, restructuring and implementation-related charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended March 31,
	2015		2014
Cost of sales	$	4	$	10
Selling, general and administrative expenses	18		17
Other (income) expense, net	78		75
Total 2012 Restructuring Program charges, pretax	$	100	$	102
Total 2012 Restructuring Program charges, aftertax	$	67	$	73

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

38

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

					Program-to-date
	Three Months Ended March 31,				Accumulated Charges
	2015		2014
North America	18	%	9	%	11	%
Latin America	—	%	4	%	3	%
Europe/South Pacific	7	%	21	%	25	%
Asia	—	%	—	%	1	%
Africa/Eurasia	3	%	2	%	5	%
Hill’s Pet Nutrition	4	%	8	%	8	%
Corporate	68	%	56	%	47	%

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $846 ($623 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2015
Employee-Related Costs	$	330
Incremental Depreciation	57
Asset Impairments	2
Other	457
Total	$	846

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the extension of shared business services and streamlining of global functions; restructuring how the Company will provide future retirement benefits to substantially all of its U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the closing of the Morristown, New Jersey personal care facility.

39

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2015
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2014	$	85		$	—		$	—	$	107		$	192
Charges	35			6			—		59			100
Cash payments	(15		)	—			—		(26		)	(41		)
Charges against assets	(8		)	(6		)	—		—			(14		)
Foreign exchange	(5		)	—			—		(1		)	(6		)
Balance at March 31, 2015	$	92		$	—		$	—	$	139		$	231

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $8 for the three months ended March 31, 2015, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits to the Condensed Consolidated Financial Statements).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2015 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $12 and contract termination costs and charges resulting directly from exit activities of $3 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2015 are other exit costs of $44 related to the consolidation of facilities.

40

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP). Management believes this measure provides investors with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments. A reconciliation of organic sales growth to Net sales growth for the three months ended March 31, 2015 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, effective tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and, as applicable, excluding charges related to the 2012 Restructuring Program, a charge related to the 2014 Venezuela Remeasurements and costs related to the sale of land in Mexico (non-GAAP). Management believes these non-GAAP financial measures provide investors with useful supplemental information regarding the performance of the Company’s ongoing operations. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three months ended March 31, 2015 and 2014 is presented within the applicable section of Results of Operations.

The Company uses the above financial measures internally in its budgeting process and as a factor in determining compensation. While the Company believes that these non-GAAP financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

The following table provides a quantitative reconciliation of organic sales growth to Net sales growth for the three months endedMarch 31, 2015.

Three months ended March 31, 2015	Organic Sales Growth (Non-GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Net Sales Growth (GAAP)
Oral, Personal and Home Care
North America	1.5%	(1.0)%	0.0%	0.5%
Latin America	9.0%	(15.0)%	0.5%	(5.5)%
Europe/South Pacific	1.0%	(15.0)%	(0.5)%	(14.5)%
Asia	(0.5)%	(1.5)%	0.5%	(1.5)%
Africa/Eurasia	8.0%	(23.0)%	0.0%	(15.0)%
Total Oral, Personal and Home Care	4.0%	(10.5)%	0.0%	(6.5)%
Pet Nutrition	5.5%	(8.0)%	0.0%	(2.5)%
Total Company	4.0%	(10.0)%	0.0%	(6.0)%

41

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, costs related to the 2012 Restructuring Program and stock repurchases). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations decreased 11% to $727 in the first three months of 2015, compared with $820 in the comparable period of 2014. The decrease in the first three months of 2015 is primarily due to a decrease in Operating profit excluding a charge related to the 2014 Venezuela Remeasurements, charges related to the 2012 Restructuring Program and costs related to the sale of land in Mexico in both periods as applicable and an increase in Other current assets driven by higher tax receivables.

The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). Overall, the Company’s working capital improved to (1.3%) of Net sales in the first three months of 2015 as compared to (0.8%) in the first three months of 2014, primarily due to an increase in Accrued income taxes and a decrease in Inventories, partially offset by an increase in Other current assets.

Approximately 75% of total program charges related to the 2012 Restructuring Program, estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax), are expected to result in cash expenditures. Savings from the 2012 Restructuring Program are projected to be in the range of $405 to $475 pretax ($340 to $390 aftertax) annually by the fourth year of the program, substantially all of which are expected to increase future cash flows. The anticipated pretax charges for 2015 are expected to amount to approximately $330 to $385 ($245 to $285 aftertax) and savings in 2015 are expected to amount to approximately $80 to $100 pretax ($60 to $75 aftertax). It is anticipated that cash requirements for the 2012 Restructuring Program will be funded from operating cash flows. Approximately 50% of the restructuring accrual at March 31, 2015 is expected to be paid in the next twelve months.

Investing activities used $257 of cash in the first three months of 2015, compared with $249 in the comparable period of 2014. Purchases of marketable securities and investments increased in the first three months of 2015 to $252 from $151 in the comparable period of 2014 primarily due to an increase in bank deposits with original maturities greater than 90 days and an increase in the Company’s investments through its subsidiary in Venezuela in local currency-denominated fixed interest rate bonds issued by the Venezuelan government. In 2011, the Company’s Mexican subsidiary entered into an agreement to sell the Mexico City site on which its commercial operations, technology center and soap production facility were located. During 2011 and 2012, the Company received the first and second installments of $24 and $36, respectively, related to the sale of land in Mexico. The parties subsequently amended that agreement to extend the closing date and are in the process of negotiating an additional amendment. Under the existing agreement, the final installment of the purchase price is due upon the transfer of the property, which is subject to the Company’s satisfaction of certain closing conditions relating to site preparation by May 19, 2015. While these conditions are not expected to be fully satisfied by May 19, 2015, in which case the Purchaser has several options under the agreement (including termination and the return to it of the first two installments of the purchase price), based on the discussions to date, the Company believes that the transfer of the property is still likely to occur in 2015. Capital spending decreased in the first three months of 2015 to $122 from $168 in the comparable period of 2014. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. Capital expenditures for 2015 are expected to remain at an annual rate of approximately 4.5% of Net sales, which is higher than the historical rate of approximately 3.5%, primarily due to the 2012 Restructuring Program.

Financing activities used $641 of cash during the first three months of 2015 compared with cash provided of $303 in the comparable period of 2014, primarily due to lower proceeds from the issuances of debt in the first three months of 2015 compared to the first three months of 2014.

42

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Long-term debt, including the current portion, decreased to $6,110 as of March 31, 2015 as compared to $6,132 as of December 31, 2014 and total debt decreased to $6,128 as of March 31, 2015 as compared to $6,148 as of December 31, 2014. The Company’s debt issuances support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the first quarter of 2014, the Company issued $500 of five-year notes at a fixed rate of 1.75% and $500 of ten-year notes at a fixed rate of 3.25%. The debt issuances were U.S. dollar denominated and were under the Company’s shelf registration statement. Proceeds from the debt issuances in the first quarter of 2014 were used for general corporate purposes which included the retirement of commercial paper borrowings and were also used to repay and retire $250 of U.S. dollar denominated notes and €250 of euro denominated notes, both of which became due in the second quarter of 2014.

As of March 31, 2015 and December 31, 2014, domestic and foreign commercial paper outstanding was $227 and $255, respectively. The average daily balances outstanding for commercial paper in the first three months of 2015 and 2014 were $2,036 and $1,405, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its line of credit that expires in 2019.

Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

In the first quarter of 2015, the Company increased the annualized common stock dividend by 6% to $1.52 per share, effective in the second quarter of 2015. On February 19, 2015, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2015 Program”), which replaced a previously authorized share repurchase program (the “2011 Program”). The Company commenced the repurchase of shares of the Company’s common stock under the 2015 Program beginning February 19, 2015.

Cash and cash equivalents decreased $230 during the first three months of 2015 to $859 at March 31, 2015, compared to $1,089 at December 31, 2014, most of which ($804 and $1,034, respectively) were held by the Company’s foreign subsidiaries. These amounts include $90 and $64 at March 31, 2015 and December 31, 2014, respectively, which are subject to currency exchange controls in Venezuela, limiting the total amount of Cash and cash equivalents held by the Company’s foreign subsidiaries that can be repatriated at any particular point in time. The Company regularly assesses its cash needs and the available sources to fund these needs and, as part of this assessment, the Company determines the amount of foreign earnings it intends to repatriate to help fund its domestic cash needs and provides applicable U.S. income and foreign withholding taxes on such earnings.

As of December 31, 2014, the Company had approximately $4,900 of undistributed earnings of foreign subsidiaries for which no U.S. income or foreign withholding taxes have been provided as the Company does not currently anticipate a need to repatriate these earnings. These earnings have been and currently are considered to be indefinitely reinvested outside of the U.S. and, therefore, are not subject to such taxes. Should these earnings be repatriated in the future, they would be subject to applicable U.S. income and foreign withholding taxes. As the Company operates in over 200 countries and territories throughout the world, and due to the complexities in the tax laws and the assumptions that would have to be made, it is not practicable to determine the tax liability that would arise if these earnings were repatriated.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

43

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data.

Market share data is subject to limitations on the availability of up-to-date information. We believe that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

44

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission in its rules, regulations and releases. Such statements may relate, for example, to sales or volume growth, organic sales growth, profit or profit margin growth, earnings growth, financial goals, the impact of currency devaluations and exchange controls, price or profit controls and labor unrest, including in Venezuela, cost-reduction plans including the 2012 Restructuring Program, tax rates, new product introductions, commercial investment levels or legal proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements, except as required by law. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic environment in different countries and its effect on consumer spending habits, increased competition and evolving competitive practices, currency rate fluctuations, exchange controls, price or profit controls, labor relations, changes in foreign or domestic laws or regulations or their interpretation, political and fiscal developments, the availability and cost of raw and packaging materials, the ability to maintain or increase selling prices as needed, the ability to implement the 2012 Restructuring Program as planned or differences between the actual and the estimated costs or savings under such program, changes in the policies of retail trade customers, the ability to continue lowering costs and the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, including the information set forth under the captions “Item 1A. Risk Factors” and “Cautionary Statement on Forward-Looking Statements.”

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2014.

45

COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2015 (the “Evaluation”). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. As part of the 2012 Restructuring Program, the Company has begun implementing a shared business service organization model, already successful in Europe, in all regions of the world. This implementation is expected to continue in a phased approach in future years. At this time, certain financial transaction processing activities have been transitioned to these newly established shared business services centers. The Company does not expect this transition to materially affect its internal control over financial reporting.

46

COLGATE-PALMOLIVE COMPANY

PART II.OTHER INFORMATION

Item 1.Legal Proceedings

For information regarding legal matters, please refer to Item 3 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, Note 13 to the Consolidated Financial Statements included therein and Note 11 to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

Item 1A.Risk Factors

For information regarding risk factors, please refer to Part 1, Item 1A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

47

COLGATE-PALMOLIVE COMPANY

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Shares repurchased from January 1, 2015 through February 18, 2015 were repurchased pursuant to a program approved by the Board on September 8, 2011 (the “2011 Program”). On February 19, 2015, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2015 Program”), which replaced the 2011 Program. The Company commenced the repurchase of shares of the Company’s common stock under the 2015 Program beginning February 19, 2015. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended March 31, 2015:

Month	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
January 1 through 31, 2015	897,425	$	68.60	831,700	—
February 1 through 28, 2015	1,485,650	$	69.83	1,277,684	$	4,973
March 1 through 31, 2015	2,956,711	$	69.05	2,810,000	$	4,779
Total	5,339,786	$	69.19	4,919,384

⁽¹⁾  Includes share repurchases under the 2011 Program and 2015 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

⁽²⁾  The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 420,402 shares, all of which relate to shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.

⁽³⁾  Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect on March 31, 2015. As discussed above, on February 19, 2015, the Board authorized the 2015 Program, which replaced the 2011 Program. As of January 31, 2015, there were 3,435,088 shares available to be purchased under the 2011 Program.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not Applicable.

Item 5.Other Information

None.

48

COLGATE-PALMOLIVE COMPANY

Item 6.Exhibits

Exhibit No.	Description
12	Computation of Ratio of Earnings to Fixed Charges.
31-A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31-B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32	Certificate of the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.
101	The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2015, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements.

49

COLGATE-PALMOLIVE COMPANY

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
	(Registrant)
	Principal Executive Officer:
April 30, 2015	/s/ Ian Cook
	Ian Cook
	Chairman of the Board, President and Chief Executive Officer
	Principal Financial Officer:
April 30, 2015	/s/ Dennis J. Hickey
	Dennis J. Hickey
	Chief Financial Officer
	Principal Accounting Officer:
April 30, 2015	/s/ Victoria L. Dolan
	Victoria L. Dolan
	Vice President and Corporate Controller

50

EX-12

EXHIBIT 12

COLGATE-PALMOLIVE COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in Millions)

(Unaudited)

	Three Months Ended March 31, 2015
Earnings:
Income before income taxes	$	852
Add:
Fixed charges	52
Less:
Income from equity investees	(2		)
Capitalized interest	(1		)
Income as adjusted	$	901
Fixed Charges:
Interest on indebtedness and amortization of debt expense and discount or premium	$	31
Portion of rents representative of interest factor	20
Capitalized interest	1
Total Fixed Charges	$	52
Ratio of earnings to fixed charges	17.3

EX-31.A

EXHIBIT 31-A

I, Ian Cook, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 30, 2015

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

EX-31.B

EXHIBIT 31-B

I, Dennis J. Hickey, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 30, 2015

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

EX-32

EXHIBIT 32

The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1) the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: April 30, 2015

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

XML

Retirement Plans and Other Retiree Benefits (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
United States Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Voluntary benefit plan contribution	$ 0	$ 0
Components of net periodic benefit cost
Service cost	0	0
Interest cost	25	25
Expected return on plan assets	(29)	(27)
Amortization of transition and prior service costs (credits)	0	0
Amortization of actuarial loss (gain)	12	8
Net periodic benefit cost	8	6
International Pension Benefits [Member]
Components of net periodic benefit cost
Service cost	5	5
Interest cost	8	9
Expected return on plan assets	(8)	(7)
Amortization of transition and prior service costs (credits)	0	1
Amortization of actuarial loss (gain)	3	1
Net periodic benefit cost	8	9
Other Retiree Benefits [Member]
Components of net periodic benefit cost
Service cost	4	3
Interest cost	11	10
Expected return on plan assets	(1)	0
Amortization of transition and prior service costs (credits)	0	0
Amortization of actuarial loss (gain)	7	4
Net periodic benefit cost	$ 21	$ 17

XML

Fair Value Measurements and Financial Instruments (Details 5) (Bonds Issued By Venezuelan Government [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Bonds Issued By Venezuelan Government [Member]
Venezuelan Investments [Roll Forward]
Beginning balance	$ 399	$ 685
Unrealized gain (loss) on investment	(1)	(298)
Purchases and sales during the period	33	54
Ending balance	$ 431	$ 441

XML

Restructuring and Related Implementation Charges (Details 3) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	Mar. 31, 2015
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program To Date	$ 846
Aftertax Charges Related To The Restructuring Program To Date	623
Employee-Related Costs [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program To Date	330
Incremental Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program To Date	57
Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program To Date	2
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program To Date	$ 457

XML

Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedMarch 31, 2015 and 2014 were as follows:

	2015						2014
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	(340	)	$	(352	)	$	(39	)	$	(43	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	(1		)	(1		)	3			2
Amortization of net actuarial loss, transition and prior service costs (1)	22			14			14			11
Retirement plans and other retiree benefits adjustments	21			13			17			13
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities (2)	(1		)	(1		)	(298		)	(194		)
Reclassification of (gains) losses into net earnings on available-for-sale securities (3)	—			—			211			138
Gains (losses) on available-for-sale securities	(1		)	(1		)	(87		)	(56		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	6			4			2			1
Reclassification of (gains) losses into net earnings on cash flow hedges (4)	(6		)	(4		)	(3		)	(1		)
Gains (losses) on cash flow hedges	—			—			(1		)	—
Total Other comprehensive income (loss)	$	(320	)	$	(340	)	$	(110	)	$	(86	)

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

⁽³⁾Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽⁴⁾These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

XML

Fair Value Measurements and Financial Instruments (Details 1) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Designated derivative instruments
Derivative Assets	$ 174	$ 94
Derivative Liabilities	19	7
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	13	8
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	0
Total assets derivatives	187	102
Total liabilities derivatives	19	7
Financial Instruments, Owned, at Fair Value [Abstract]
Total other financial instruments	690	564
Bonds Issued By Venezuelan Government [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	431	399	441	685
Other Current Assets [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Marketable Securities	250	200
Notes Receivable, Fair Value Disclosure	42	42
Other Current Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Marketable Securities	33
Interest Rate Swap Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	1	1
Interest Rate Swap Contracts [Member] | Other accruals [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Interest Rate Swap Contracts [Member] | Other Assets [Member]
Designated derivative instruments
Derivative Assets	16	12
Interest Rate Swap Contracts [Member] | Other Liabilities [Member]
Designated derivative instruments
Derivative Liabilities	0	2
Foreign Currency Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	36	21
Foreign Currency Contracts [Member] | Other accruals [Member]
Designated derivative instruments
Derivative Liabilities	18	4
Foreign Currency Contracts [Member] | Other Assets [Member]
Designated derivative instruments
Derivative Assets	121	60
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	13	8
Foreign Currency Contracts [Member] | Other Liabilities [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	0
Commodity Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	0	0
Commodity Contracts [Member] | Other accruals [Member]
Designated derivative instruments
Derivative Liabilities	1	1
Estimate of Fair Value Measurement [Member] | Other Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	$ 398	$ 322

XML

Earnings Per Share (Details) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share Reconciliation [Abstract]
Net income attributable to Colgate-Palmolive Company, Basic	$ 542	$ 388
Net income attributable to Colgate-Palmolive Company, Diluted	$ 542	$ 388
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic EPS (in shares)	907,700,000	919,500,000
Stock options and restricted stock (in shares)	8,600,000	9,100,000
Diluted EPS (in shares)	916,300,000	928,600,000
Earnings Per Share, Basic and Diluted [Abstract]
Earnings Per Share, Basic	$ 0.60	$ 0.42
Earnings Per Share, Diluted	$ 0.59	$ 0.42
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,566,993	3,374,995

XML

Venezuela (Details) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				3 Months Ended
	Mar. 31, 2015 USD ($)	Mar. 31, 2014 USD ($)	Mar. 31, 2014 CP Venezuela [Member] USD ($)	Mar. 31, 2015 CP Venezuela [Member] USD ($)	Mar. 31, 2015 CP Venezuela [Member] Sales Revenue, Net [Member]	Mar. 31, 2015 VENEZUELA VEF
Foreign Currency [Line Items]
Official Exchange Rate						6.30
SICAD Exchange Rate						12.00
SIMADI Exchange Rate						192.95
Pretax Remeasurement Charge	$ 0	$ 266	$ 266
Aftertax Remeasurement Charge			174
Impact of Aftertax Remeasurement Charge Per Common Share, Diluted			$ 0.19
Percentage of consolidated Net sales represented by CP Venezuela					4.00%
Bolivar fuerte denominated monetary net asset position				589
Bolivar Fuerte denominated non monetary asset position				302
Bolivar Fuerte Denominated Non Monetary Fixed Asset Position				234
Total Investment in CP Venezuela Including Intercompany Payables				$ 987

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2015

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

On April 7, 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03 “Simplifying the Presentation of Debt Issuance Costs,” which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of related debt liability, consistent with debt discounts. Under current accounting standards, such costs are recorded as an asset. The new guidance is effective for the Company beginning January 1, 2016, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On February 18, 2015, the FASB issued ASU No. 2015-02 “Consolidation (Topic 810): Amendments to the Consolidation Analysis” that amends the current consolidation guidance. The amendments affect both the variable interest entity and voting interest entity consolidation models. The new guidance is effective for the Company beginning January 1, 2016, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On May 28, 2014, the FASB and the International Accounting Standards Board (“IASB”) issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09 “Revenue from Contracts with Customers” by the FASB, provides a single, comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures which are significantly more comprehensive than those in existing revenue standards. This new guidance is currently effective for the Company beginning January 1, 2017, with no early adoption permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.

XML

Fair Value Measurements and Financial Instruments (Details 2) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Carrying Value [Member]
Debt Instrument [Line Items]
Carrying value of long-term debt	$ 6,110	$ 6,132
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 6,463	$ 6,346

XML

Acquisitions and Divestitures (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Sep. 30, 2012	Sep. 30, 2011	Oct. 03, 2014
MEXICO
Sale of Land in Mexico [Abstract]
First Installment received from the sale of land in Mexico				$ 24
Second Installment received from the sale of land in Mexico			36
Pretax costs related to sale of land	0	1
Aftertax costs related to sale of land	0	1
Oral Care Member | MYANMAR
Business Acquisition [Line Items]
Cash consideration for acquisition of business					$ 62

XML

Fair Value Measurements and Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2015

Financial Instruments and Fair Value Measurements [Abstract]

Schedule of derivative instruments

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2015 and December 31, 2014:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		3/31/15		12/31/14			3/31/15		12/31/14
Interest rate swap contracts	Other current assets	$	1	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	16		12		Other liabilities	—		2
Foreign currency contracts	Other current assets	36		21		Other accruals	18		4
Foreign currency contracts	Other assets	121		60		Other liabilities	—		—
Commodity contracts	Other current assets	—		—		Other accruals	1		1
Total designated		$	174	$	94		$	19	$	7
Derivatives not designated
Foreign currency contracts	Other assets	$	13	$	8	Other liabilities	$	—	$	—
Total not designated		$	13	$	8		$	—	$	—
Total derivative instruments		$	187	$	102		$	19	$	7
Other financial instruments
Marketable securities	Other current assets	$	250	$	200
Available-for-sale securities	Other assets	398		322
Note receivable	Other current assets	42		42
Total other financial instruments		$	690	$	564

Activity related to fair value hedges

Activity related to fair value hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015									2014
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at March 31,	$	1,213		$	1,438		$	2,651		$	681		$	1,688		$	2,369
Three months ended March 31:
Gain (loss) on derivative	2			6			8			2			(10		)	(8		)
Gain (loss) on hedged items	(2		)	(6		)	(8		)	(2		)	10			8

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015							2014
	Foreign Currency Contracts		Commodity Contracts			Total		Foreign Currency Contracts		Commodity Contracts		Total
Notional Value at March 31,	$	595	$	12		$	607	$	401	$	15	$	416
Three months ended March 31:
Gain (loss) recognized in OCI	7		(1		)	6		—		2		2
Gain (loss) reclassified into Cost of sales	7		(1		)	6		2		1		3

Activity related to net investment hedges

Activity related to net investment hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015									2014
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts		Foreign Currency Debt			Total
Notional Value at March 31,	$	768		$	273		$	1,041		$	680	$	256		$	936
Three months ended March 31:
Gain (loss) on instruments	62			27			89			—		1			1
Gain (loss) on hedged items	(62		)	(27		)	(89		)	1		(1		)	—

Activity related to derivatives not designated as hedging instruments

Activity related to this contract during the three months ended March 31, 2015 and 2014 was as follows:

	2015			2014
	Cross-currency Swap			Cross-currency Swap
Notional Value at March 31,	$	102		$	96
Three months ended March 31:
Gain (loss) on instrument	5			(1		)
Gain (loss) on hedged item	(5		)	1

Reconciliation of the Venezuelan investments at fair value

The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months endedMarch 31, 2015 and 2014:

	2015			2014
Beginning balance as of January 1,	$	399		$	685
Unrealized gain (loss) on investment	(1		)	(298		)
Purchases and sales during the period	33			54
Ending balance as of March 31,	$	431		$	441

XML

Fair Value Measurements and Financial Instruments (Details 3) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 102	$ 96
Activity related to derivatives not designated as hedging instruments [Abstract]
Gain (loss) on instrument	5	(1)
Gain (loss) on hedged item	(5)	1
Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	2,651	2,369
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	8	(8)
Gain (loss) on hedged items	(8)	8
Fair Value Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,213	681
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	2	2
Gain (loss) on hedged items	(2)	(2)
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,438	1,688
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	6	(10)
Gain (loss) on hedged items	(6)	10
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	607	416
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	6	2
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	595	401
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	7	0
Cash Flow Hedging [Member] | Commodity Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	12	15
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	(1)	2
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,041	936
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	89	1
Gain (loss) on hedged items	(89)	0
Net Investment Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	768	680
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	62	0
Gain (loss) on hedged items	(62)	1
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	273	256
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	27	1
Gain (loss) on hedged items	(27)	(1)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member]
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	6	3
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	7	2
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | Commodity Contracts [Member]
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	$ (1)	$ 1

XML

Restructuring and Related Implementation Charges (Details) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2012	Mar. 31, 2015
Restructuring Cost and Reserve [Line Items]
Duration Of The Restructuring Program	4 years
Expected Percent Of Total Charges Resulting In Cash Expenditure		75.00%
Employee-Related Costs [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		50.00%
Incremental Depreciation And Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		10.00%
Charges Resulting Directly From Exit Activities [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		20.00%
Implementation Of New Strategies [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		20.00%
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		10.00%
Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		40.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		15.00%
Europe/South Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		20.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		5.00%
Asia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		5.00%
Africa/Eurasia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		5.00%
Expected Completion Date 2016 [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax		$ 1,285
Restructuring Program Expected Cost After Tax		950
Restructuring and Related Cost, Positions Eliminated [Abstract]
Restructuring And Related Cost, Expected Number Of Positions Eliminated		2,000
Expected Completion Date 2016 [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax		1,435
Restructuring Program Expected Cost After Tax		1,050
Restructuring and Related Cost, Positions Eliminated [Abstract]
Restructuring And Related Cost, Expected Number Of Positions Eliminated		2,500
Expected Completion Date December 2015 [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax		330
Restructuring Program Expected Cost After Tax		245
Expected Completion Date December 2015 [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax		385
Restructuring Program Expected Cost After Tax		$ 285

XML

Restructuring and Related Implementation Charges (Details 1) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program	$ 100	$ 102
Aftertax Charges Related To The Restructuring Program	67	73
Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program	4	10
Selling, General and Administrative Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program	18	17
Other (Income) Expense, Net [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related To The Restructuring Program	$ 78	$ 75

XML

Use of Estimates

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of Estimates

Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

XML

Restructuring and Related Implementation Charges (Details 2) (Two Thousand Twelve Restructuring Program [Member])	3 Months Ended		30 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	4.00%	8.00%
Percent Of Restructuring Charges Related to Segment Program To Date			8.00%
Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	68.00%	56.00%
Percent Of Restructuring Charges Related to Segment Program To Date			47.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	18.00%	9.00%
Percent Of Restructuring Charges Related to Segment Program To Date			11.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	0.00%	4.00%
Percent Of Restructuring Charges Related to Segment Program To Date			3.00%
Europe/South Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	7.00%	21.00%
Percent Of Restructuring Charges Related to Segment Program To Date			25.00%
Asia [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	0.00%	0.00%
Percent Of Restructuring Charges Related to Segment Program To Date			1.00%
Africa/Eurasia [Member]
Restructuring Cost and Reserve [Line Items]
Percent Of Total Restructuring Charges Related To Segment For The Period	3.00%	2.00%
Percent Of Restructuring Charges Related to Segment Program To Date			5.00%

XML

Contingencies (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015 country_and_territory
Loss Contingency [Abstract]
Minimum Number Of Countries And Territories Serving Consumers	200
Range of reasonably possible losses, minimum	$ 0
Range of reasonably possible losses, maximum	200
Brazilian internal revenue authority, matter 1	90
Brazilian internal revenue authority, matter 2	55
European competition matters - Swiss competition law authority	6
European competition matters - Spanish competition law authority	3
European competition matters - Italian competition law authority	3
Fine Imposed French Competition Authority	57
Fine Imposed French Competition Authority - As a result of Sanex Acquisition	25
European competition matters - Hill's France Subsidiary	$ 7

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015 Dividend		Mar. 31, 2014 Dividend
Net sales	$ 4,070		$ 4,325
Cost of sales	1,678		1,801
Gross profit	2,392		2,524
Selling, general and administrative expenses	1,450		1,544
Other (income) expense, net	82		346
Operating profit	860		634
Interest (income) expense, net	8		7
Income before income taxes	852		627
Provision for income taxes	269		195
Net income including noncontrolling interests	583		432
Less: Net income attributable to noncontrolling interests	41		44
Net income attributable to Colgate-Palmolive Company	$ 542		$ 388
Earnings per common share, basic (in dollars per share)	$ 0.60		$ 0.42
Earnings per common share, diluted (in dollars per share)	$ 0.59		$ 0.42
Dividends declared per common share (in dollars per share)	$ 0.74	[1]	$ 0.70	[1]
Number of Dividends Declared Per Quarter	2		2

[1] Two dividends were declared in each period.

XML

Fair Value Measurements and Financial Instruments (Details 4) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela	$ 276
Bonds Issued By Venezuelan Government [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities	441	431	399	685
Other Current Assets [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable Securities		250	200
Fair Value, Inputs, Level 1 [Member] | Other Current Assets [Member] | Deposits [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable Securities		217
Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair Value of U.S. dollar-linked, devaluation-protected bonds		72
Fair Value of fixed interest rate bonds		359
Fair Value, Inputs, Level 2 [Member] | Other Current Assets [Member] | Bonds Issued By Venezuelan Government [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable Securities		33
Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member] | Other Assets [Member] | Bonds Issued By Venezuelan Government [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities		$ 398	$ 322

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Operating Activities
Net income including noncontrolling interests	$ 583	$ 432
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	114	108
Restructuring and termination benefits, net of cash	57	45
Venezuela remeasurements charges	0	266
Stock-based compensation expense	32	34
Deferred income taxes	(22)	(21)
Cash effects of changes in:
Receivables	(150)	(77)
Inventories	(23)	(67)
Accounts payable and other accruals	111	100
Other non-current assets and liabilities	25	0
Net cash provided by operations	727	820
Investing Activities
Capital expenditures	(122)	(168)
Purchases of marketable securities and investments	(252)	(151)
Proceeds from sale of marketable securities and investments	110	74
Payments for acquisitions, net of cash acquired	0	(25)
Other	7	21
Net cash used in investing activities	(257)	(249)
Financing Activities
Principal payments on debt	(2,171)	(1,938)
Proceeds from issuance of debt	2,105	2,960
Dividends paid	(329)	(316)
Purchases of treasury shares	(374)	(453)
Proceeds from exercise of stock options and excess tax benefits	128	50
Net cash (used in) provided by financing activities	(641)	303
Effect of exchange rate changes on Cash and cash equivalents	(59)	(41)
Net (decrease) increase in Cash and cash equivalents	(230)	833
Cash and cash equivalents at beginning of the period	1,089	962
Cash and cash equivalents at end of the period	859	1,795
Supplemental Cash Flow Information
Income taxes paid	$ 164	$ 171

XML

Inventories (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Raw materials and supplies	$ 323	$ 349
Work-in-process	56	55
Finished goods	971	978
Total Inventories	$ 1,350	$ 1,382

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2015

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories By Major Class

Inventories by major class are as follows:

	March 31, 2015		December 31, 2014
Raw materials and supplies	$	323	$	349
Work-in-process	56		55
Finished goods	971		978
Total Inventories	$	1,350	$	1,382

XML

Shareholders' Equity (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	$ 1,385
Net income	583	432
Other comprehensive income, net of tax	(339)	(87)
Ending balance	739
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	2,805		2,453
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	1,051		1,064
Common Stock [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			1,466
Ending balance	1,466		1,466
Additional Paid-In Capital [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	1,236
Stock-based compensation expense	32
Shares issued for stock options	32
Stock issued for restricted stock awards	(29)
Other	1
Ending balance	1,272
Unearned Compensation [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	(20)
Other	7
Ending balance	(13)
Treasury Stock [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	(16,862)
Shares issued for stock options	85
Stock issued for restricted stock awards	29
Treasury stock acquired	(374)
Ending balance	(17,122)
Retained Earnings [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	18,832
Net income	542
Dividends	(670)
Ending balance	18,704
Accumulated Other Comprehensive Income (Loss) [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	(3,507)
Other comprehensive income, net of tax	(340)
Ending balance	(3,847)
Noncontrolling Interests [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	240
Net income	41
Other comprehensive income, net of tax	1
Dividends	(3)
Ending balance	$ 279

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	Three Months Ended
	March 31, 2015					March 31, 2014
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	542	907.7	$	0.60	$	388	919.5	$	0.42
Stock options and restricted stock units			8.6					9.1
Diluted EPS	$	542	916.3	$	0.59	$	388	928.6	$	0.42

For the three months endedMarch 31, 2015 and 2014, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,566,993 and 3,374,995, respectively.

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission.

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Net income including noncontrolling interests	$ 583	$ 432
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	(351)	(44)
Retirement Plan and other retiree benefit adjustments	13	13
Gains (losses) on available-for-sale securities	(1)	(56)
Gains (losses) on cash flow hedges	0	0
Total Other comprehensive income (loss), net of tax	(339)	(87)
Total Comprehensive income including noncontrolling interests	244	345
Less: Net income attributable to noncontrolling interests	41	44
Less: Cumulative translation adjustments attributable to noncontrolling interests	1	(1)
Total Comprehensive Income attributable to noncontrolling interests	42	43
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 202	$ 302

XML

Contingencies

3 Months Ended

Mar. 31, 2015

Loss Contingency [Abstract]

Contingencies

Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $200 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $90. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process since October 2001. Numerous appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts. The Company intends to challenge these assessments vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $55, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company has been disputing the assessment within the internal revenue authority’s administrative appeals process. In November 2014, the Superior Chamber of Administrative Tax Appeals denied the Company’s most recent appeal. Further appeals are available both at the administrative level and within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

Competition Matters

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues, as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

European Competition Matters

Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases fines, by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court.

▪ In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) pursuant to a Business and Share Sale and Purchase Agreement (the “Sanex Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is entitled to indemnification for this fine under the Sanex Purchase Agreement and is seeking indemnification from Unilever. The Company is appealing both fines in the French courts.

Currently, formal claims of violations or statements of objections are pending against the Company as follows:

▪ In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices in the Belgian market. The defendants have initiated preliminary talks with the authority regarding a possible settlement.

▪ In July 2014, the Greek competition law authority issued a statement of objections alleging the Company and its Greek subsidiary restricted parallel imports into Greece. The Company has responded to this statement of objections.

Since December 31, 2014, the following matter has been resolved:

▪ In March 2015, the French Supreme Court confirmed the French competition law authority’s March 2012 fine of the Company’s Hill’s French subsidiary in the amount of $7.

Australian Competition Matter

In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra concentrated laundry detergents. The Company is defending these proceedings. Since the amount of any potential losses from these proceedings currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings.

Talcum Powder Matters

The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. The Company is challenging these cases vigorously. Nineteen cases filed against the Company have been dismissed and had final judgment entered in favor of the Company. In April 2015, an agreement in principle was reached to settle four individual cases following a trial and jury verdict in one of the cases in California against the Company and others. The amount of the settlement in principle is not material to the Company’s results of operations for the quarter ended March 31, 2015.

There are 13 additional individual cases pending against the Company in state courts in Illinois, Maryland, New Jersey, New York and South Carolina. Some of these cases are expected to go to trial in 2015, although the Company may succeed in dismissing or otherwise resolving them. While the Company and its legal counsel believe these cases are without merit and intend to challenge them vigorously, there can be no assurances of the outcome at trial. Since the amount of any potential losses from these additional cases currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2015
Entity Information [Line Items]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	904,569,917
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	false
Trading Symbol	CL
Document Period End Date	Mar. 31, 2015

XML

Segment Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended
	March 31,
	2015			2014
Net sales
Oral, Personal and Home Care
North America	$	789		$	785
Latin America	1,087			1,152
Europe/South Pacific	741			865
Asia	661			672
Africa/Eurasia	254			298
Total Oral, Personal and Home Care	3,532			3,772
Pet Nutrition	538			553
Total Net sales	$	4,070		$	4,325
Operating profit
Oral, Personal and Home Care
North America	$	218		$	216
Latin America	308			290
Europe/South Pacific	184			217
Asia	193			193
Africa/Eurasia	39			59
Total Oral, Personal and Home Care	942			975
Pet Nutrition	147			144
Corporate	(229		)	(485		)
Total Operating profit	$	860		$	634

Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months endedMarch 31, 2015, Corporate Operating profit (loss) includes charges of $100 related to the 2012 Restructuring Program. For the three months endedMarch 31, 2014, Corporate Operating profit (loss) included charges of $102 related to the 2012 Restructuring Program, a charge of $266 related to the 2014 Venezuela Remeasurements and costs of $1 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 859	$ 1,089
Receivables (net of allowances of $58 and $54, respectively)	1,611	1,552
Inventories	1,350	1,382
Other current assets	880	840
Total current assets	4,700	4,863
Property, plant and equipment:
Cost	8,212	8,385
Less: Accumulated depreciation	(4,244)	(4,305)
Property, plant and equipment, net	3,968	4,080
Goodwill	2,186	2,307
Other intangible assets, net	1,356	1,413
Deferred income taxes	79	76
Other assets	867	720
Total assets	13,156	13,459
Current Liabilities
Notes and loans payable	18	16
Current portion of long-term debt	488	488
Accounts payable	1,167	1,231
Accrued income taxes	417	294
Other accruals	2,233	1,917
Total current liabilities	4,323	3,946
Long-term debt	5,622	5,644
Deferred income taxes	233	261
Other liabilities	2,239	2,223
Total liabilities	12,417	12,074
Shareholders' Equity
Common stock	1,466	1,466
Additional paid-in capital	1,272	1,236
Retained earnings	18,704	18,832
Accumulated other comprehensive income (loss)	(3,847)	(3,507)
Unearned compensation	(13)	(20)
Treasury stock, at cost	(17,122)	(16,862)
Total Colgate-Palmolive Company shareholders' equity	460	1,145
Noncontrolling interests	279	240
Total shareholders' equity	739	1,385
Total liabilities and shareholders' equity	$ 13,156	$ 13,459

XML

Inventories

3 Months Ended

Mar. 31, 2015

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories

Inventories

Inventories by major class are as follows:

	March 31, 2015		December 31, 2014
Raw materials and supplies	$	323	$	349
Work-in-process	56		55
Finished goods	971		978
Total Inventories	$	1,350	$	1,382

XML

Restructuring and Related Implementation Charges

3 Months Ended

Mar. 31, 2015

Restructuring and Related Activities [Abstract]

Restructuring And Related Implementation Charges

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

On October 23, 2014, the Company’s Board of Directors approved an expansion of the Global Growth and Efficiency Program (as expanded, the “2012 Restructuring Program”) to take advantage of additional savings opportunities.

Cumulative pretax charges related to the 2012 Restructuring Program, once all phases are approved and implemented, are estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax). Implementation of the 2012 Restructuring Program is expected to be substantially completed by December 31, 2016. These pretax charges are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (20%). Anticipated pretax charges for 2015 are expected to amount to approximately $330 to $385 ($245 to $285 aftertax). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, by the end of 2016, the 2012 Restructuring Program will contribute a net reduction of approximately 2,000-2,500 positions from the Company’s global employee workforce.

For the three months ended March 31, 2015 and 2014, restructuring and implementation-related charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended March 31,
	2015		2014
Cost of sales	$	4	$	10
Selling, general and administrative expenses	18		17
Other (income) expense, net	78		75
Total 2012 Restructuring Program charges, pretax	$	100	$	102
Total 2012 Restructuring Program charges, aftertax	$	67	$	73

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

					Program-to-date
	Three Months Ended March 31,				Accumulated Charges
	2015		2014
North America	18	%	9	%	11	%
Latin America	—	%	4	%	3	%
Europe/South Pacific	7	%	21	%	25	%
Asia	—	%	—	%	1	%
Africa/Eurasia	3	%	2	%	5	%
Hill’s Pet Nutrition	4	%	8	%	8	%
Corporate	68	%	56	%	47	%

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $846 ($623 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2015
Employee-Related Costs	$	330
Incremental Depreciation	57
Asset Impairments	2
Other	457
Total	$	846

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the extension of shared business services and streamlining of global functions; restructuring how the Company will provide future retirement benefits to substantially all of its U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the closing of the Morristown, New Jersey personal care facility.

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2015
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2014	$	85		$	—		$	—	$	107		$	192
Charges	35			6			—		59			100
Cash payments	(15		)	—			—		(26		)	(41		)
Charges against assets	(8		)	(6		)	—		—			(14		)
Foreign exchange	(5		)	—			—		(1		)	(6		)
Balance at March 31, 2015	$	92		$	—		$	—	$	139		$	231

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $8 for the three months ended March 31, 2015, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2015 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $12 and contract termination costs and charges resulting directly from exit activities of $3 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2015 are other exit costs of $44 related to the consolidation of facilities.

XML

Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Changes in the components of Shareholders’ Equity for the three months endedMarch 31, 2015 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2014	$	1,466	$	1,236		$	(20	)	$	(16,862	)	$	18,832		$	(3,507	)	$	240
Net income												542						41
Other comprehensive income (loss), net of tax															(340		)	1
Dividends												(670		)				(3		)
Stock-based compensation expense			32
Shares issued for stock options			32						85
Shares issued for restricted stock awards			(29		)				29
Treasury stock acquired									(374		)
Other			1			7
Balance, March 31, 2015	$	1,466	$	1,272		$	(13	)	$	(17,122	)	$	18,704		$	(3,847	)	$	279

Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,805 and $2,453 at March 31, 2015 and December 31, 2014, respectively, and unrecognized retirement plan and other retiree benefits costs of $1,051 and $1,064 at March 31, 2015 and December 31, 2014, respectively.

XML

Fair Value Measurements and Financial Instruments

3 Months Ended

Mar. 31, 2015

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.  

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2015 and December 31, 2014:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		3/31/15		12/31/14			3/31/15		12/31/14
Interest rate swap contracts	Other current assets	$	1	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	16		12		Other liabilities	—		2
Foreign currency contracts	Other current assets	36		21		Other accruals	18		4
Foreign currency contracts	Other assets	121		60		Other liabilities	—		—
Commodity contracts	Other current assets	—		—		Other accruals	1		1
Total designated		$	174	$	94		$	19	$	7
Derivatives not designated
Foreign currency contracts	Other assets	$	13	$	8	Other liabilities	$	—	$	—
Total not designated		$	13	$	8		$	—	$	—
Total derivative instruments		$	187	$	102		$	19	$	7
Other financial instruments
Marketable securities	Other current assets	$	250	$	200
Available-for-sale securities	Other assets	398		322
Note receivable	Other current assets	42		42
Total other financial instruments		$	690	$	564

The carrying amount of cash, cash equivalents, accounts receivable, a note receivable and short-term debt approximated fair value as of March 31, 2015 and December 31, 2014. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2015 and December 31, 2014, was $6,463 and $6,346, respectively, and the related carrying value was $6,110 and $6,132, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair Value Hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015									2014
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at March 31,	$	1,213		$	1,438		$	2,651		$	681		$	1,688		$	2,369
Three months ended March 31:
Gain (loss) on derivative	2			6			8			2			(10		)	(8		)
Gain (loss) on hedged items	(2		)	(6		)	(8		)	(2		)	10			8

Cash Flow Hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015							2014
	Foreign Currency Contracts		Commodity Contracts			Total		Foreign Currency Contracts		Commodity Contracts		Total
Notional Value at March 31,	$	595	$	12		$	607	$	401	$	15	$	416
Three months ended March 31:
Gain (loss) recognized in OCI	7		(1		)	6		—		2		2
Gain (loss) reclassified into Cost of sales	7		(1		)	6		2		1		3

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net Investment Hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three months ended March 31, 2015 and 2014 was as follows:

	2015									2014
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts		Foreign Currency Debt			Total
Notional Value at March 31,	$	768		$	273		$	1,041		$	680	$	256		$	936
Three months ended March 31:
Gain (loss) on instruments	62			27			89			—		1			1
Gain (loss) on hedged items	(62		)	(27		)	(89		)	1		(1		)	—

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. 

Activity related to this contract during the three months ended March 31, 2015 and 2014 was as follows:

	2015			2014
	Cross-currency Swap			Cross-currency Swap
Notional Value at March 31,	$	102		$	96
Three months ended March 31:
Gain (loss) on instrument	5			(1		)
Gain (loss) on hedged item	(5		)	1

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities and a fixed interest rate note receivable. Marketable securities consist of bank deposits of $217 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $33. The long-term portion of these bonds in the amount of $398 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and bolivar denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of March 31, 2015, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds was $72 and $359, respectively. These bonds are considered available-for-sale securities and, as noted above, the long-term portion in the amount of $398 is included in Other assets.

The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months endedMarch 31, 2015 and 2014:

	2015			2014
Beginning balance as of January 1,	$	399		$	685
Unrealized gain (loss) on investment	(1		)	(298		)
Purchases and sales during the period	33			54
Ending balance as of March 31,	$	431		$	441

Unrealized loss on investment for the three months endedMarch 31, 2014 consisted primarily of a charge of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

For further information regarding Venezuela, refer to Note 14, Venezuela.

XML

Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Other Comprehensive Income (Loss)

Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedMarch 31, 2015 and 2014 were as follows:

	2015						2014
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	(340	)	$	(352	)	$	(39	)	$	(43	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	(1		)	(1		)	3			2
Amortization of net actuarial loss, transition and prior service costs (1)	22			14			14			11
Retirement plans and other retiree benefits adjustments	21			13			17			13
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities (2)	(1		)	(1		)	(298		)	(194		)
Reclassification of (gains) losses into net earnings on available-for-sale securities (3)	—			—			211			138
Gains (losses) on available-for-sale securities	(1		)	(1		)	(87		)	(56		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	6			4			2			1
Reclassification of (gains) losses into net earnings on cash flow hedges (4)	(6		)	(4		)	(3		)	(1		)
Gains (losses) on cash flow hedges	—			—			(1		)	—
Total Other comprehensive income (loss)	$	(320	)	$	(340	)	$	(110	)	$	(86	)

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

⁽³⁾Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽⁴⁾These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

XML

Shareholders' Equity

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the three months endedMarch 31, 2015 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2014	$	1,466	$	1,236		$	(20	)	$	(16,862	)	$	18,832		$	(3,507	)	$	240
Net income												542						41
Other comprehensive income (loss), net of tax															(340		)	1
Dividends												(670		)				(3		)
Stock-based compensation expense			32
Shares issued for stock options			32						85
Shares issued for restricted stock awards			(29		)				29
Treasury stock acquired									(374		)
Other			1			7
Balance, March 31, 2015	$	1,466	$	1,272		$	(13	)	$	(17,122	)	$	18,704		$	(3,847	)	$	279

Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,805 and $2,453 at March 31, 2015 and December 31, 2014, respectively, and unrecognized retirement plan and other retiree benefits costs of $1,051 and $1,064 at March 31, 2015 and December 31, 2014, respectively.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

	Three Months Ended
	March 31, 2015					March 31, 2014
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	542	907.7	$	0.60	$	388	919.5	$	0.42
Stock options and restricted stock units			8.6					9.1
Diluted EPS	$	542	916.3	$	0.59	$	388	928.6	$	0.42

For the three months endedMarch 31, 2015 and 2014, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,566,993 and 3,374,995, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

XML

Retirement Plans and Other Retiree Benefits

3 Months Ended

Mar. 31, 2015

Compensation and Retirement Disclosure [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three months ended March 31, 2015 and 2014 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended March 31,
	2015			2014			2015			2014			2015			2014
Service cost	$	—		$	—		$	5		$	5		$	4		$	3
Interest cost	25			25			8			9			11			10
Expected return on plan assets	(29		)	(27		)	(8		)	(7		)	(1		)	—
Amortization of transition and prior service costs (credits)	—			—			—			1			—			—
Amortization of actuarial loss (gain)	12			8			3			1			7			4
Net periodic benefit cost	$	8		$	6		$	8		$	9		$	21		$	17

For the three months endedMarch 31, 2015 and March 31, 2014, the Company did not make any voluntary contributions to its U.S. postretirement plans.

XML

Restructuring and Related Implementation Charges (Details 4) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Restructuring Cost and Reserve [Line Items]
Beginning Balance	$ 192
Charges	100	102
Cash payments	(41)
Charges against assets	(14)
Foreign exchange	(6)
Ending Balance	231
Employee-Related Costs [Member]
Restructuring Cost and Reserve [Line Items]
Beginning Balance	85
Charges	35
Cash payments	(15)
Charges against assets	(8)
Foreign exchange	(5)
Ending Balance	92
Incremental Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Beginning Balance	0
Charges	6
Cash payments	0
Charges against assets	(6)
Foreign exchange	0
Ending Balance	0
Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Beginning Balance	0
Charges	0
Cash payments	0
Charges against assets	0
Foreign exchange	0
Ending Balance	0
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Beginning Balance	107
Charges	59
Cash payments	(26)
Charges against assets	0
Foreign exchange	(1)
Ending Balance	139
Third Party Incremental Cost [Member]
Restructuring Cost and Reserve [Line Items]
Charges	12
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Charges	3
Land And Building [Member]
Restructuring Cost and Reserve [Line Items]
Charges	$ 44

XML

Restructuring and Related Implementation Charges (Tables)

3 Months Ended

Mar. 31, 2015

Restructuring and Related Activities [Abstract]

Schedule Of Restructuring And Related Costs

For the three months ended March 31, 2015 and 2014, restructuring and implementation-related charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended March 31,
	2015		2014
Cost of sales	$	4	$	10
Selling, general and administrative expenses	18		17
Other (income) expense, net	78		75
Total 2012 Restructuring Program charges, pretax	$	100	$	102
Total 2012 Restructuring Program charges, aftertax	$	67	$	73

Schedule Of Percent Of Total Restructuring Charges Related To Segment For The Period

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

					Program-to-date
	Three Months Ended March 31,				Accumulated Charges
	2015		2014
North America	18	%	9	%	11	%
Latin America	—	%	4	%	3	%
Europe/South Pacific	7	%	21	%	25	%
Asia	—	%	—	%	1	%
Africa/Eurasia	3	%	2	%	5	%
Hill’s Pet Nutrition	4	%	8	%	8	%
Corporate	68	%	56	%	47	%

Schedule Of Restructuring And Related Costs Incurred To Date

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $846 ($623 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2015
Employee-Related Costs	$	330
Incremental Depreciation	57
Asset Impairments	2
Other	457
Total	$	846

Schedule Of Restructuring Reserve By Type Of Cost

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2015
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2014	$	85		$	—		$	—	$	107		$	192
Charges	35			6			—		59			100
Cash payments	(15		)	—			—		(26		)	(41		)
Charges against assets	(8		)	(6		)	—		—			(14		)
Foreign exchange	(5		)	—			—		(1		)	(6		)
Balance at March 31, 2015	$	92		$	—		$	—	$	139		$	231

XML

Retirement Plans and Other Retiree Benefits (Tables)

3 Months Ended

Mar. 31, 2015

Compensation and Retirement Disclosure [Abstract]

Components Of Net Periodic Benefit Cost

Components of Net periodic benefit cost for the three months ended March 31, 2015 and 2014 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended March 31,
	2015			2014			2015			2014			2015			2014
Service cost	$	—		$	—		$	5		$	5		$	4		$	3
Interest cost	25			25			8			9			11			10
Expected return on plan assets	(29		)	(27		)	(8		)	(7		)	(1		)	—
Amortization of transition and prior service costs (credits)	—			—			—			1			—			—
Amortization of actuarial loss (gain)	12			8			3			1			7			4
Net periodic benefit cost	$	8		$	6		$	8		$	9		$	21		$	17

XML

Segment Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting Information [Line Items]
Total Net sales	$ 4,070	$ 4,325
Total Operating profit	860	634
MEXICO
Segment Reporting Information [Line Items]
Pretax costs related to sale of land	0	1
Operating Segments [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	3,532	3,772
Total Operating profit	942	975
Operating Segments [Member] | Pet Nutrition [Member]
Segment Reporting Information [Line Items]
Total Net sales	538	553
Total Operating profit	147	144
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	789	785
Total Operating profit	218	216
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	1,087	1,152
Total Operating profit	308	290
Operating Segments [Member] | Europe/South Pacific [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	741	865
Total Operating profit	184	217
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	661	672
Total Operating profit	193	193
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	254	298
Total Operating profit	39	59
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Total Operating profit	(229)	(485)
Two Thousand Twelve Restructuring Program [Member]
Segment Reporting Information [Line Items]
Pretax Charges Related To The Restructuring Program	100	102
Sales Revenue, Net [Member]
Segment Reporting Information [Line Items]
Percentage of Consolidated Net Sales represented by Sales outside US	80.00%
Percentage of Consolidated Net Sales coming from Emerging Markets	50.00%
CP Venezuela [Member]
Segment Reporting Information [Line Items]
Venezuela Remeasurement Charges		$ 266

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 58	$ 54

XML

Acquisitions and Divestitures

3 Months Ended

Mar. 31, 2015

Business Combinations [Abstract]

Acquisitions and Divestitures

Acquisitions and Divestitures

Acquisition

On October 3, 2014, the Company acquired an oral care business in Myanmar for $62 in cash plus additional consideration contingent upon achievement of performance targets under a distribution services agreement.

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America (the “Purchaser”) the Mexico City site on which its commercial operations, technology center and soap production facility were located. The sale price is payable in three installments. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The parties subsequently amended that agreement to extend the closing date and are in the process of negotiating an additional amendment. Under the existing agreement, the final installment of the purchase price is due upon the transfer of the property, which is subject to the Company’s satisfaction of certain closing conditions relating to site preparation by May 19, 2015. While these conditions are not expected to be fully satisfied by May 19, 2015, in which case the Purchaser has several options under the agreement (including termination and the return to it of the first two installments of the purchase price), based on the discussions to date, the Company believes that the transfer of the property is still likely to occur in 2015. The Company has reinvested the first two installments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months endedMarch 31, 2015 and 2014, the Company recorded $0 and $1 of pretax costs ($0 and $1 of aftertax costs), respectively, related to the sale.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Three Months Ended
	March 31,
	2015			2014
Net sales
Oral, Personal and Home Care
North America	$	789		$	785
Latin America	1,087			1,152
Europe/South Pacific	741			865
Asia	661			672
Africa/Eurasia	254			298
Total Oral, Personal and Home Care	3,532			3,772
Pet Nutrition	538			553
Total Net sales	$	4,070		$	4,325
Operating profit
Oral, Personal and Home Care
North America	$	218		$	216
Latin America	308			290
Europe/South Pacific	184			217
Asia	193			193
Africa/Eurasia	39			59
Total Oral, Personal and Home Care	942			975
Pet Nutrition	147			144
Corporate	(229		)	(485		)
Total Operating profit	$	860		$	634

XML

Other Comprehensive Income (Loss) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Equity [Abstract]
Cumulative translation adjustments, before-tax	$ (340)		$ (39)
Cumulative translation adjustment, net-of-tax	(352)		(43)
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period, before-tax	(1)		3
Net actuarial gains (losses) and prior service costs arising during the period, net-of-tax	(1)		2
Amortization of net actuarial loss, transition & prior service costs, before-tax	22	[1]	14	[1]
Amortization of net actuarial loss, transition & prior service costs, net-of-tax	14	[1]	11	[1]
Retirement Plan and other retiree benefit adjustments, before-tax	21		17
Retirement Plan and other retiree benefit adjustments, net-of-tax	13		13
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities, before-tax	(1)	[2]	(298)	[2]
Unrealized gains (losses) on available-for-sale securities, net-of-tax	(1)	[2]	(194)	[2]
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax	0	[3]	211	[3]
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax	0	[3]	138	[3]
Gains (losses) on available-for-sale securities, before-tax	(1)		(87)
Gains (losses) on available-for-sale securities, net-of-tax	(1)		(56)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges, before-tax	6		2
Unrealized gains (losses) on cash flow hedges, net-of-tax	4		1
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax	(6)	[4]	(3)	[4]
Reclassification of (gains) losses into net earnings on cash flow hedges, net-of-tax	(4)	[4]	(1)	[4]
Gains (losses) on cash flow hedges, before-tax	0		(1)
Gains (losses) on cash flow hedges, net-of-tax	0		0
Total other comprehensive income (loss), before-tax	(320)		(110)
Total other comprehensive income (loss), net-of-tax	(340)		(86)
Remeasurement Due To Change in Foreign Exchange Rates [Abstract]
Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela			$ 276

[1] These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

[2] For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

[3] Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

[4] These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

XML

Venezuela

3 Months Ended

Mar. 31, 2015

Foreign Currency [Abstract]

Venezuela

Venezuela

Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.

In February 2015, the Venezuelan government implemented changes in Venezuela’s foreign exchange regime. While the official exchange rate, as determined by the National Center for Foreign Commerce (“CENCOEX”), remains at 6.30 bolivares per dollar and the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market, now known as SICAD, is unchanged, the SICAD II market was eliminated and a new, alternative currency market, the Foreign Exchange Marginal System (“SIMADI”), was created and became operational with a floating exchange rate determined by market participants.

The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is currently the SICAD rate. During the quarter ended March 31, 2015, the SICAD rate did not revalue, remaining at 12.00 bolivares per dollar as of March 31, 2015.

During the quarter ended March 31, 2014, the Company incurred pretax losses of $266 ($174 aftertax losses, or $0.19 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD rate. Included in the remeasurement losses were charges related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remained at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD currency market but remained at the official exchange rate, resulting in an impairment in the fair value of the bonds.

CP Venezuela funds its requirements for imported goods through a combination of U.S. dollars obtained from CENCOEX and intercompany borrowings. Because most of the products in CP Venezuela’s portfolio have been designated as “essential” by the Venezuelan government, CP Venezuela’s access to U.S. dollars at the official rate of 6.30 bolivares per dollar has generally been sufficient to settle most of its U.S. dollar obligations for imported materials and the gains related to such transactions are recorded when the funds are authorized by CENCOEX and the liabilities are paid.

Although the SIMADI market was accessible to CP Venezuela, it did not participate in the market through March 31, 2015. Since its inception, the volume of transactions in the SIMADI market has been very limited and the exchange rate at March 31, 2015 was 192.95 bolivares per dollar.

For the three months endedMarch 31, 2015, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At March 31, 2015, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD rate, was $589. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated net non-monetary assets were $302 at March 31, 2015 and included $234 of fixed assets that could be subject to impairment if CP Venezuela is not able to implement further price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars from CENCOEX or the SICAD market to fund imports.

Additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing, payments, profits or imports or other governmental actions or continued or increased labor unrest would further negatively affect the Company’s business in Venezuela and the Company’s ability to effectively make key operational decisions in regard to its Venezuelan operations, both of which could result in an impairment of the Company’s investment in CP Venezuela. At March 31, 2015, the Company’s total investment in CP Venezuela was $987, which included intercompany payables of CP Venezuela.